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ABSTRACT 
 
An External Dose Reconstruction Involving a Radiological Dispersal Device. 
(December 2006) 
David Wayne Hearnsberger, B.S., Texas A&M University; 
M.S., Texas A&M University 
Co-Chairs of Advisory Committee: Dr. Ian S. Hamilton 
Dr. John W. Poston, Sr. 
Recent events have underscored the need for the United States government to 
provide streamlined emergency response procedures and subsequent dose estimations for 
personnel responding to incidents involving radioactive material.  Indeed, the National 
Council on Radiation Protection and Measurements Report No. 138 (NCRP 2001) indicates 
that exposures received by first responders will be important for a number of reasons, 
including planning for the appropriate use of key personnel in an extended emergency 
situation.  In response, the Department of Homeland Security has published Protective 
Action Guides (DHS 2006) to help minimize these exposures and associated risks.   
 This research attempts to provide some additional radiological exposure knowledge 
so that an Incident Commander, with limited or no information, can make more informed 
decisions about evacuation, sheltering-in-place, relocation of the public, turn-back levels, 
defining radiation hazard boundaries, and in-field radiological dose assessments of the 
radiation workers, responders, and members of the public.  A method to provide such 
insight begins with providing a model that describes the physics of radiation interactions, 
radiation source and geometry, collection of field measurements, and interpretation of the 
collected data.  A Monte Carlo simulation of the model is performed so that calculated 
iv 
results can be compared to measured values. 
 The results of this investigation indicate that measured organ absorbed doses 
inside a tissue equivalent phantom compared favorably to the derived organ absorbed 
doses measured by the Panasonic thermoluminescence dosimeters and with Monte Carlo 
‘N’ Particle modeled results.  Additionally, a Victoreen 450P pressurized ion chamber 
measured the integrated dose and these results compared well with the Panasonic right 
lateral TLD.  This comparison indicates that the Victoreen 450P ionization chamber could 
potentially serve as an estimator of real-time effective dose and organ absorbed dose, if 
energy and angular dependence corrections could be taken into account.  Finally, the data 
obtained in this investigation indicate that the MCNP model provided a reasonable method 
to determine organ absorbed dose and effective dose of a simulated Radiological Dispersal 
Device in an Inferior-Superior geometry with Na99mTcO4 as the source of radioactive 
material. 
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I. INTRODUCTION 
 With increased awareness of terrorist activities that seek to compromise the United 
States domestically, and our interests abroad, the need to provide streamlined emergency 
response procedures and subsequent dose estimates for personnel responding to 
incidents involving radioactive material has never been more important.  In response to this 
growing awareness, several United States (US) government agencies have set out to 
develop procedures and plans for incidents involving radiological dispersal devices (RDD) 
and/or improvised nuclear devices (IND).  For instance, the Environmental Protection 
Agency (EPA) is developing a Radiation Playbook that provides guidance for On-Scene 
Coordinators (OSC) on how to collect radiological data during the initial few hours after the 
onset of a radiological incident.  The Department of Energy (DOE) has published, through 
the Federal Radiological Monitoring and Assessment Center (FRMAC), three assessment 
manuals, two monitoring manuals, an emergency operations manual, and a health and 
safety manual.  Other agencies have published information but, in all cases, the plans and 
procedures must be developed according to the National Response Plan (NRP) managed 
by the Department of Homeland Security (DHS) (NRP December 2004)*. 
 With documents such as the NRP, the National Contingency Plan (NCP) and the 
National Incident Management System (NIMS), there is literally a sea of information 
available to anyone interested in federal radiological emergency response.  The “person in 
charge” of responding to incidents requiring federal involvement is known as the Incident 
Commander (IC).  In a scenario involving RDDs or INDs, the IC (after a time) is a member 
of the FBI (FBI, 1998) during the period of crisis management.  If such a device is 
                                                 
This dissertation follows the style and format of Health Physics. 
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detonated, then the consequence management period begins and the IC changes to state 
and local authorities and federal authorities such as the EPA OSC or a representative from 
the Federal Emergency Management Agency (FEMA).  The IC relies on local, county, 
state, and federal agencies for information needed to determine whether to recommend ad 
hoc respiratory protection, evacuation, relocation, or shelter-in-place for those who may 
become collaterally involved in such an incident.  For example, Musolino and Harper 
(2006) provided modeling and measurement information derived from the data collected 
from over 500 explosive experiments involving about twenty different materials with eighty-
five device geometries to develop recommendations for the early phase response.  They 
recommend the evacuation of the public occur at a 50-year committed dose of 500 mSv 
(50 rem), while DHS (2006) and EPA (1992) recommend evacuation occur at 50 mSv (5 
rem), but should begin at 10 mSv (1 rem).  Another example is that Musolino and Harper 
(2006) recommend sheltering in place at a 50-year committed dose of 50 mSv (5 rem) and 
the DHS and EPA recommend sheltering at 10 mSv to 50 mSv (1 rem to 5 rem) but should 
normally begin at 10 mSv (1 rem).  It is interesting to note that in terms of life-saving efforts 
and/or protection of critical infrastructure, EPA (1992) recommends a maximum dose 
equivalent of 250 mSv (25 rem) while NCRP (2001), with proper risk information provided, 
recommends a maximum dose equivalent of 500 mSv (50 rem).  
 Note, however, that collection and interpretation of radiological data are two of the 
most important factors when designing radiological emergency plans, and procedures.  The 
most important information needed by the IC are the magnitude and extent of the projected 
dose.  Whether the information provided is expressed in terms of dose rate, radioactive 
airborne concentration, loose surface contamination levels, or values derived from direct-
reading radiation detection instrumentation for external penetrating radiation, the 
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information that guides an IC to a decision is the projected dose.  Musolino and Harper 
(2006) state that strategies and decisions to protect emergency responders, based on 
projected dose and dose rate, must be made in the planning stages rather than just after 
an attack occurs. 
 The objectives of this research are: 
• simulate a planar source of radioactivity similar to that produced by a 
radiological dispersal device; 
• measure the external radiation exposure at selected locations on the 
surface of a suitable phantom; 
• measure the organ doses inside a suitable phantom due to this radiation 
field;  
• relate the above results with measurements made with a portable ionization 
chamber (x-ray and gamma-ray radiation); and 
• compare the measured results with those obtained through Monte Carlo 
simulation of the exposure geometry. 
 
 The Monte Carlo code can be used to model the source of radiation, assumed 
geometry, radiation transport, internal organs of the body, and to calculate the absorbed 
dose to selected internal organs.  The organ absorbed doses are calculated using the 
Monte Carlo N-Particle, Version 4C (Briesmeister 2000).  The experiment measured the 
organ absorbed dose and also estimated the effective dose at four different locations on 
the outside of a tissue-equivalent phantom.  
Figure 1 shows the logic flow used to validate the MCNP model, verify International 
Commission on Radiological Protection (ICRP) Report No. 74 (ICRP 1996) conversion 
coefficients, and how organ absorbed dose was determined.  Verification of ICRP Report 
No. 74 conversion coefficients involved comparing the derived organ absorbed dose 
obtained using Panasonic UD-802 TLDs to the MCNP-calculated organ absorbed dose. 
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II. BACKGROUND 
II.1 Gamma Ray Physics and Radiation Sources
 The radiation source chosen for this investigation was technetium.  All isotopes of 
technetium are man-made and all are radioactive (Nuclides and Isotopes 2002).  The 
specific isotope of technetium used in this experiment was the metastable form of 
technetium-99 (99mTc) in the chemical form of sodium pertechnetate (Na99mTcO4).  The 
primary gamma-ray energy of the 99mTc is approximately 140 keV with an absolute yield of 
89.06 percent.  Figure 2 shows the relative abundance of this gamma ray is 100 percent, 
and the authors of the Nuclear Data Sheets indicate that to determine the absolute 
abundance, one should multiply the relative abundance by a factor of 0.8906 (Tuli et al, 
2001). 
 Although gamma rays of this energy predominantly interact with air, water, and 
tissue via the Compton Scattering effect, photoelectric interactions occur as well.  
Identification of these events is important because they describe the interaction processes 
the gamma rays undergo to deposit energy in the body.  Deposition of this energy results in 
absorbed dose.  Figure 3 shows the interaction regions for the gamma ray energies from 
0.01 MeV to 100 MeV. 
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Figure 2: The 99mTc decay scheme from the Nuclear Data Sheets. 
 
 
 
 
7 
 
Figure 3: Probability of interaction of photons with a given energy versus the effective 
atomic number (After Attix 1986). 
 
 
 
II.2 Sodium Pertechnetate Background Information
The Na99mTcO4 used in this study is a very common radiopharmaceutical and is the 
most widely used radiodiagnostic agent in use today (Shikata and Iguchi, 1986).  Typically, 
the 99mTc is chemically separated from the parent radionuclide, molybdenum-99 (99Mo), 
inside a portable chromatographic generator by adsorbing the 99Mo on an alumina column 
and rinsing the less strongly bound, water soluble TcO-4 ion at key intervals with isotonic 
saline (Monroy-Guzman et al 2003).  The total activity may vary from generator to 
generator depending upon the needs of the recipient, but one may assume that about 740 
GBq (about 20 Ci) of 99mTc in the form of Na99mTcO4 can be obtained from a typical 
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generator*ξ. 
II.3 Principles of Thermoluminescence Dosimetry
Considered by many to be a separate branch of science, radiation dosimetry 
literally means, radiation dose measurement.  The goal of radiation dosimetry is to 
establish the energy deposited per unit mass in a suitable receptor.  Quantitative 
measurements involve using various types of dosimeters and evaluation systems to 
retrieve the information stored in the dosimetry system.  Experiments conducted for this 
study used thermoluminescence dosimeters (TLD).  As the name implies, heat is used to 
evaluate (“read”) the thermoluminescence dosimeters to retrieve the stored information in 
the TLD.  More specifically, the TLDs used were lithium fluoride crystals doped with 
magnesium and titanium impurities (LiF:Mg,Ti, also called TLD-100). 
II.3.a Phosphors
TLDs are made of small crystalline dielectric insulator material that contains 
interstitial defects in the crystal structure.  These interstitial defects give the dielectric its 
thermoluminescence properties.  For TLD-100, the interstitial defects are caused by the 
introduction of magnesium (Mg) and titanium (Ti) into the crystal – expressed as LiF:(Mg, 
Ti).  These interstitial defects serve two purposes. 
Interstitial defects in the crystal structure create “traps” and “holes.”  The traps 
retain electrons while the holes can capture and hold the charge carriers in a potential 
energy well for long periods of time.  The other purpose of the defects is to create 
luminescence centers, located at either electron traps or the hole traps, which emit light 
when the electrons or holes are permitted to recombine.  Attix (1986) provides a convenient 
                                                 
*.Personal communication with Danny Allen of NuTech, 2003 
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energy-level diagram to understand this phenomenon in Figure 4 below. 
 
 
 
 
Figure 4: Energy-level diagram of the thermoluminescence process (after Attix 1986). 
 
 
 
 Part A in Figure 4 depicts phosphor excitation by radiation (i.e., raising an electron 
into the conduction band, where it migrates to an electron trap).  The hole that is left behind 
migrates to a hole trap.  During the heating process to “read” the TLD (depicted in Part B), 
assuming the electron is at a more shallow trapping depth than the hole, the electron is 
released first into the conduction band and migrates into a hole trap.  The hole trap may be 
assumed to act as a luminescence center, or closely coupled to one, such that the 
recombining of the electron with the luminescence center releases a visible light photon 
(Attix 1986).  One may further assume that the intensity of the released visible light photons 
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is directly proportional to the amount of radiant energy deposited. 
II.3.b General Characteristics of Dosimeters
There are several general characteristics of dosimeters, but the discussion will be 
limited to the characteristics relevant for this investigation. 
II.3.b (1) Precision and Bias
 In the context of radiation dosimetry, precision is better defined to mean 
reproducibility.  The precision of a radiation dosimeter concerns random fluctuations in 
instrument characteristics, ambient conditions, the stochastic nature of a radiation field, etc. 
For clarity, a high precision implies a low standard deviation (Attix 1986).  Whereas the 
precision describes how closely a single measurement compares to the expected value, 
accuracy expresses how closely the expected value compares to the true value.  To state 
that a dosimeter is a precise measuring instrument is to mean that it is capable of very 
good measurement reproducibility if deployed correctly.  To state that a dosimeter is a very 
accurate instrument is to mean that freedom from error is relatively high (i.e., the dosimeter 
is relatively unbiased). 
II.3.b (2) Dose Range
 To be useful, a dosimeter must have an ability to detect doses over the range of 
interest.  The dosimeter should exhibit a well-established relationship between the actual 
and indicated doses.  For many dosimeters, this is a linear relationship.  Ideally, this 
property should be expressed from doses as low as about ten µGy (1 mrad) to about 1000 
Gy (about 100,000 rad).  The upper limit is generally a physical limitation of the particular 
dosimeter.  For example, some of the physical limitations are the following (Attix 1986): 
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• Exhaustion of the supply of atoms, molecules, or solid-state entities (“traps”) being 
acted upon by the radiation producing the reading; 
• Competing reactions by radiation products, for example in chemical dosimeters; 
and 
• Radiation damage to the dosimeter (e.g., discoloration of light-emitting dosimeters, 
or damage to electrical insulators). 
 
Mostly, the upper limit of the dose range is manifested by a deviation from the well-
established dosimeter response. 
II.3.b (3) Dose-Rate Range
 The absorbed dose is the parameter of interest in this research.  Since the radiation 
exposure continued throughout an extended period, an integrating-type dosimeter is 
necessary to measure the absorbed dose.  It is also necessary that the dosimeter response 
should be independent of dose rate.  Since the activity used in this experiment produces 
moderate levels of dose, one need not be concerned with a low-dose rate limitation such 
as that presented by insulator leakage current in an ion chamber or such limitations in a 
photographic film dosimeter.  Moreover, the high dose rate limitations caused by charged 
particle tracks being created closely enough together in space and time (volumetric 
recombination) to allow the electron-hole pairs to interact between tracks is not a significant 
concern for this experiment for the same reason. 
II.3.b (4) Stability
 The foregoing characteristics of a dosimeter should be stable both before and after 
irradiation.  With regard to “prior-to-use” irradiation periods, the dosimeter should retain its 
sensitivity when exposed to variable ambient changes in temperature, atmospheric 
pressure, humidity, and light (Pederson et al 1995).  The TLD-100 material used in this 
experiment exhibits a gradual sensitivity change due to migration and rearrangement of the 
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trapping centers in the phosphor, but this is controlled by the annealing process.  In 
contrast, the TLD-100 can experience a “fading” effect after irradiation, and before it is 
read, by losing some of the trapped charge carriers.  Normally, to correct for this fading, all 
the TLDs are “read” at the same time after irradiation.  The annealing process adds 
additional energy to eliminate the very low-energy traps, making the TLD more stable and 
reducing the fading. 
II.3.b (5) Energy Dependence
 Generally speaking, one would desire that the dosimeter used does not have a 
response that is dependent upon the incident radiation energy being measured.  This is 
often not the case, however.  For photons with an energy significantly below 100 keV and 
for a dosimeter that has an effective atomic number greater than that of air, one finds that 
the dosimeters have a tendency to over-respond as shown in Figure 5. 
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Zg=Zair
Zg<Zair
Zg>Zair
Figure 5: Typical energy-dependence curves in terms of the response per unit exposure 
of x- or γ-rays (taken after Attix 1986). 
 
 
 
In the experiment conducted with Na TcO99m
cobalt-60 gamma rays.  The rise in 
sponse below 100 keV is due to the domination of photoelectric interactions.  The small 
ecreases at the left end of the graph are due to photoelectric effect and attenuation in the 
dosimeter.  Figure 6 shows the actual (instead of typical) energy-dependent response of 
the TLD-100 material.  Figure 6 indicates that the thermoluminescence (TL) response per 
rad is about 1.08, or about eight percent over-response due to 140 keV photons.  An over-
response factor of 1.08 is assumed in these experiments, since the exact energy of the 
impinging gamma rays on the TLDs is not known.   
 
 
4, the 140-keV photon has an energy 
dependent response of about 1.0 in air, relative to 
re
d
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Figure 6: Thermoluminescent response of LiF per roentgen and per rad for photon 
energies from 6 to 2800 keV (after Attix 1986). 
 
 
 
II.3.b (6) Angular Dependence
 One of three operational dose quantities defined by the International Commission 
on Radiation Units and Measurements (ICRU) (ICRU 1985, 1988, 1992, 1993), directional 
dose equivalent (H’(d, α)), is related to the ICRP Report No. 60 protection quantities (ICRP 
1991).  In general, operational quantities are related to protection quantities by 
measurement and calculation using radiation weighting factors, tissue weighting factors, 
and anthropomorphic phantoms (ICRP 1996).  In this instance, directional dose equivalent 
is an operational quantity, whose response to the angle of the incident radiation will affect 
the results of the protection quantity, organ absorbed dose.  In this investigation, the over-
response or under-response of a dosimeter was taken into account by applying organ – 
and geometry – specific conversion coefficients developed in ICRP Report No. 74 (ICRP 
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1  
with an individual dosimeter.  Understanding this phenomenon is important since the 
subtended angle of the incident radiation can result in a lower than expected deposition of 
energy, which will result in an underestimation of the absorbed dose. 
 
 
 
 
996).  Figure 7 below shows the subtended angle, α, that the incident radiation makes
 
Figure 7: Definition of the angle, α, subtended by incident radiation (after ICRP 1996). 
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 ICRP (1996) discusses five fundamental exposure geometries, i.e., anterior-
posterior (AP), posterior-anterior (PA), lateral (LAT for left and right), rotational (ROT), and 
isotropic (ISO).  In the rotational (ROT) geometry, a unidirectional radiation field is applied 
while the slab or anthropomorphic phantom is rotated in either a clockwise or a counter-
clockwise direction.  As the phantom rotates about the vertical axis, the angle of incident 
radiation changes from zero to 360 degrees.  ICRP (1996) states in paragraph 144 that:  
 
the ROT geometry is seen as an approximation to irradiation from a widely 
dispersed planar source (e.g. as would be likely from environmental contamination). 
 
While not all dosimeter measurements can be conducted at all angles of incidence during 
this rotational process, one can approximate the changes in dosimeter response based on 
a few pre-selected locations on the phantom. 
 The proposed Inferior-Superior (IS) geometry provides a surrogate to the ROT 
geometry for applying correction factors to dosimeters exposed at varying angles to photon 
radiation.  In this case, the incident angle of radiation from the ground surface to the 
d
the 
phantom is approximately 1.5 meters in height.  Figure 8, from ICRP (1996), shows the 
response for varying photon energies.  The direction of incidence is orthogonal to 
the transverse axis of the body. 
osimeter changes from zero degrees to a maximum of sixty-three degrees since the 
radius of the radioactive source is three meters and the point of dosimetric interest on 
angular 
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Figure 8: The angular variation of effective dose for photons; effective dose per unit air 
kerm energetic parallel photon beams incident at various 
angles on an adult anthropomorphic computational model (ICRP 1996). 
 
 
 
With vertically varying incidence, one can see that the ICRP (1996) conversion 
coefficients increase in both the anterior and posterior positions (anterior is more 
pronounced) and decrease sharply when the angle is both proximal (top) and distal 
(bottom) to the exposed phantom.  This sharp decrease is due to several factors such as 
asymmetrical organs, but is caused mostly by the increased shielding of organs by the 
a in free air, E/Ka, for mono
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body.  Applying a maximum angle of incidence of sixty degrees to Figure 8, one can 
estimate that the conversion coefficients for a 140 keV photon will vary from 1.3, 1.05, and 
0.75 when the incident angle changes from zero, to thirty, and sixty degrees, respectively, 
as measured from the front towards the bottom.  This would indicate that an arithmetic 
average response would be approximately 1.03 for all angles zero through sixty degrees 
clusive. 
II.3.c Randall-Wilkins Theory
in
A first-order kinetics approximation for escape of trapped charge carriers at a given 
temperature was first described by Randall and Wilkins in 1945 through the following 
equation (Attix 1986): 
kT
E
eP
−== ατ
1
    Eq.1 
where, 
 P is the probability of escape per unit time (s-1), 
 τ is the mean lifetime in the trap, 
 α is called the frequency factor, 
 E is the energy depth of the trap (eV), 
 k is Boltzman’s constant (k=1.381 x 10-23 J K-1), 
 
spection of this equation would lead one to assume that if k, E, and α are held constant, 
creasing T will cause P to increase and τ to decrease.  In more meaningful terms, this 
T is temperature in Kelvin. 
 
In
in
implies that, for a constant incident radiation energy and frequency factor, an increase in 
temperature applied to the TLD will result in an increase in the probability that an electron 
will escape back into the conduction band, recombine with a thermoluminescence center, 
and release visible light photons.   
 It follows that if one increases the temperature linearly as a function of time, the 
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escape rate of trapped electrons will increase and reach a maximum release rate based on 
some maximum temperature.  If it is further assumed that the intensity of the light emission 
is proportional to the electron escape rate, a corresponding peak in thermoluminescence 
brightness will occur at the maximum temperature.  This peak is called a “glow peak” and is 
shown in Figure 9. 
 
 
 
 
Figure 9: A thermoluminescence glow curve versus temperature (after Attix 1986). 
 
 
 
The multiple peaks shown in the glow curve in Figure 9 are due to the thermoluminescence 
phosphor containing two different trap depths.  The “IR” or “Spurious” markings are 
presented on the graph to indicate that a temperature greater than 300°C results in the 
infrared spectrum, produced by the heating element, contributing to the detected brightness 
of the glow curve.  Generally, flowing an inert gas, such as nitrogen, into the TLD heating 
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area can reduce this occurrence, although in modern dosimetry systems, this phenomenon 
is of little significance.   
yII.3.d Trap Stabilit
If the traps are not stable at room temperature, as discussed in section II.3.b (4), 
they may migrate through the crystal structure and combine with other traps to form 
different configurations.  TLD-100 exhibits this property to some extent.  This problem is 
minimized by annealing the TLD prior to and after use.  Another stability problem with TLDs 
is trap leakage.  Trap leakage is the inability of the phosphor material to hold charge 
carriers at ambient temperatures after irradiation.  Typically, the lower the temperature of 
the glo
II.3.e Intrinsic Efficiency of TLD Phosphors
w peak, the greater the effect of trap leakage after irradiation occurs (Attix 1986).   
It should be noted that only a small portion of the energy deposited in a TLD 
phosphor is emitted as light when the phosphor is heated.  The ratio of TL light energy 
thermoluminescence efficiency.  The intrinsic thermoluminescence efficiency of TLD-100 is 
about 0.039% (Attix 1986). 
emitted per unit mass compared to total deposited energy is called the intrinsic 
II.4 MCNP Simulation
 Monte Carlo transport methods are very different from deterministic transport 
methods.  Deterministic methods solve the transport equation for the average particle 
behavior and Monte Carlo methods simulate individual particles and record some aspects 
(tallies) of their average behavior (Briesmeister, 2000).  The average behavior of particles 
in the experiments is inferred from the average behavior of the simulated particles.  The 
details of how the MCNP code utilizes geometry cards, variance reduction techniques, tally 
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cards, cross section libraries, materi als cards, particle tracking, and source definitions is 
discussed next. 
II.4.a Tally Cards
Tally cards are used to specify what calculations the MCNP code will be instructed 
to perform.  MCNP provides six standard neutron and photon tallies and four standard 
electron tallies (Briesmeister, 2000).  The tallies used in this report averaged photon flux 
over a cell (F4 Tally) in units of particles cm , and averaged energy deposition in a cell (F6 
Tally) in units of MeV g .  Absorbed dose is expressed in the units of grays (Gy), where 
one Gy is equal to one joule kg .   
In MCNP, a cell represents a region of dosimetric interest.  In the calculations 
described here, a cell does not necessarily represent an entire organ.  Instead, several 
small volumes of each organ were used to tally the amount of energy deposited per gram 
 F6 tally.  The tally volumes used were two cm3.  The 
 particles cm-2 to 
absorbed dose in rem.  To conform to the SI Units System, the unit rem must be converted 
to the unit Sv and so the results from the F4 tally are divided by 100 since 1 Sv is equal to 
-2
-1
-1
of tissue in the tally volume using an
number of tallies for an individual organ was summed, an arithmetic average determined, 
and the average organ absorbed dose calculated.  Applying a quality factor of one to 
absorbed dose due to the type of radiation received converts the absorbed dose (in Gy) to 
the dose equivalent in sieverts (Sv).  The units of Gy and Sv are the same and neither of 
the tallies mentioned above could be used to calculate absorbed dose directly.  Applying a 
fluence to dose conversion factor to the F4 tally converts the result from
100 rem.  Applying a multiplier to convert MeV g-1 to J kg-1 and Gy to Sv provided the final 
tally results in units of Sv for the F6 tally. 
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II.4.b MCNP Geometry Definitions
MCNP version 4C comes equipped with various types of geometry specifications, 
tallies, materials definitions, source specifications, and variance reduction techniques.  The 
geometry used in MCNP treats an arbitrary three-dimensional configuration of user-defined 
materials in geometric cells bounded by first- and second-degree surfaces and fourth-
degree elliptical tori.  The cells are defined by intersections, unions, and complements of 
the regions bounded by the surfaces and are treated in a Cartesian coordinate system.  
Surfaces are defined by supplying coefficients to the analytical surface equations, or for 
certain types of surfaces, known points on the surface.  In the MCNP code, the operator 
has the added flexibility of defining geometrical regions from all the first- and second-
Boolean operators. 
degree surfaces of analytical geometry and elliptical tori and then combining them with 
II.4.c Materials Description Cards
 The materials description cards in MCNP specify both the isotopic composition of 
the materials and the cross section evaluations to be used in the cells.  The entries on the 
materials description cards are in the form of ZAID.nnX followed by the appropriate fraction 
of that particular element.  In this expression, Z represents the atomic number of the 
element, A represents the mass number, ID is the identification that is added to make the 
Mnemonic ZAID, nn is the library identifier, and X is the class of data. 
II.4.d Source Definition Card
 A source definition card, SDEF, is one of four available methods of defining starting 
DEF card defin s the basic source parameters, such as position, starting 
rticle.  If the user 
particles.  The S e
cell number, starting energy, starting weight, starting time, and type of pa
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wants to define a source other than a point isotropic source, then the Source Information 
(SI) and Source Probability (SP) cards should be used.  The SI card defines either values 
of the source variable or some distribution numbers.  Coupled to the SI card is the SP card. 
 The SP card entries are probabilities that correspond to the entries on the SI card.  In 
some cases, when long distances exist between the source particle and the target, a 
Source Bias (SB) card may be utilized.  The SB card is used to provide a probability 
distribution for sampling that is different from the true probability distribution on the SP 
card.  Its purpose is to bias the sampling of its source variable to improve the convergence 
rate of the problem.  The weight of each source particle is adjusted to compensate for the 
bias. 
.4.e Variance Reduction TechniquesII
 There are four classes of variance reduction techniques used in MCNP.  The four 
lasses are truncation methods, population control methods, modified sampling methods, 
nd partially-deterministic methods.  For the sake of brevity, only the modified sampling 
ethod technique used in this study will be discussed herein.  Source biasing in MCNP, 
lthough not completely general, allows the production of more source particles, with 
ppropriately reduced weights, in the more important regimes of each variable.  Source 
irectional biasing, used in this model, can be sampled from an exponential density 
nction  
c
a
m
a
a
d
fu
( ) µµ KCep = ,     Eq. 2 
here, 
 
w
( )KK ee KC −−= ,  
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  θµ cos= , where θ is the angle relative to the biasing direction. 
K is ypically equal to one and defines the ratio of weight of tracks starting in the biasing 
direction to tracks starting in the opposite direction.  In this experiment, K=3.5 since this 
increases the amount o directional biasing towards the receptor.
 t
f   Thus, the ratio is equal to 
1/1097, or 9.12 x10-4. 
II.4.f The Dispersal Model
 The MCNP model was used to simulate the experimental dose measurements 
using the Na99mTcO4 radiation source.  Figure 10 represents the experimental setup used 
in the study. 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Inferior-superior ® phantom. 
 
 
 
99mTc exposure geometry  for the Rando
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The radius of the semi-circular geometry in Figure 10 was three meters and the region 
contained 360 liters of water, 71 liters of olive oil (with 55% to 80% oleic acid) and the 
Na99mTcO4 solution.  The 360 liters of water allowed a water depth of 2.5 cm and the 71 
liters of olive oil added another 0.5 cm.  Ten mL of Na TcO4 solution containing an 
activity of 7.4 GBq of Tc was dispersed onto the oleic acid. 
 The geometry used in the MCNP model assumed that water was located on the 
bottom of the semi-circle as the first layer.  This was followed by oleic acid on top of the 
water as the middle layer, and finally the Na TcO4 solution as the third and final layer.  
The materials cards used in the MCNP code described the water as H2O with a density of 
18 34O2
4
 
 
 
 
 
Figure 11: MCNP model depicting layered water, olive oil, and Na99mTcO4 and room 
barriers. 
99m
99m
99m
1.0 g cm-3, the olive oil as pure oleic acid, C H  with a density of 0.895 g cm-3, and the 
Na99mTcO  solution contained a total of 2.3 x 1014 atoms of 99mTc.  To account for scatter of 
the 99mTc gamma rays, the MCNP model also included the concrete floors, walls, and 
ceiling.  Figure 11 below shows the geometry used in the MCNP model calculation.  The 
room was 7m wide by 25m long, one meter thick concrete walls, and 5m high ceiling. 
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II.4.g The Phantom Model
 The MCNP software can be used to simulate the human body through use of 
various geometry and material cards available as a standard feature of the software 
package.  The MCNP user’s manual covers the technical use and description of the 
materials and geometry cards discussed in section II.4.b.  Since simulation of the human 
body is complex and time consuming, the amount of computing time can be intensive 
because particle tracking must occur through a variety of surfaces.  All tissues and organs 
used in this simulation derived their descriptions from the ICRP (1975).  As an additional 
aid, a software pac Rando® phantom 
and respective organs.  This software was used to provide an MCNP-based description of 
an age and sex-specific human body for use as an input to the MCNP transport code.  In 
this investigation, an adult male described as “The Reference Man” by ICRP (1975) was 
modele
                                                
kage known as Body Builder†ψwas used to model the 
d.  Figure 12 shows the internal structure of the model. 
 
†ψWhite Rock Science, P.O. Box 729 White Rock, NM 87544, 505-672-1105. 
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Figure 12: MCNP modeled adult male human body. 
ere not simulated and, thus, no particle 
interaction or tracking occurred during the computer simulations.  This choice was made 
due to the use of the Rando® phantom.  The phantom did not have arms during the 
experimental process and so, in an attempt to construct as representative a model as 
possible, the arms were not simulated.  The Rando® phantom did not have legs either, so 
the experimental setup used planks of wood to simulate legs.  This also provided a means 
to mount the phantom at the proper height above the planar source. 
 
 
 
Although arms are included in Figure 12, the arms were “commented out” during 
the MCNP simulations.  That is, the arms w
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III. MATERIALS AND METHODS 
Preparation of the Source GeometryIII.1 
 The semi-circular geometry needed for the investigation was constructed by using  
4-mil plastic sheeting,‡†laminate plastic moulding track§‡to have the plastic retain the semi-
circular shape needed, and binder clips**§to hold the plastic sheeting to the plastic 
moulding. The semi-circle source geometry was constructed in the basement of the Zachry 
Engineering Center at Texas A&M University in an area where ingress and egress could be 
closely monitored and only those personnel involved in the investigation could enter.   
After assembly of the plastic sheeting and moulding track, water was carefully 
applied over the surface of the plastic and provided a 2.5 cm thick hydrophilic binding 
surface for the 0.5 cm thick olive oil (containing the oleic acid).   
III.2 Preparation of the Rando® Phantom 
® After constructing the irradiation source geometry, the Rando  phantom was moved 
into place, as shown in Figure 10 of section II.4.f of this report.  Figure 13 is a photograph 
of the Rando® phantom used in this investigation.  Note that the phantom is transected-
horizontally, where each slice is 2.5 cm thick. 
                                                 
‡†Manufactured by t King ermw duct pany
Mahwah, NJ 07430 Model Number P1014. 
§
‡Shaw Industries, Inc.  P.O. Drawer 2128 616 E. Walnut Avenue Dalton, GA 30722-2128 
**
§OfficeMax Corporate Headquarters 150 E. Pierce Road Itasca, IL 60143 Item # 20168809 
 Fros  – Th ell Pro s Com , Inc., 420 Route 17 South 
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Figure 13: Photograph of the Rando® phantom. 
 
 
 
 The segments of the phantom are printed with a unique identifier number on the 
anterior portion of the phantom and the slices used in this investigation ranged from slice 
number 16 to 31, which contained organs from the top of the lungs down to the colon on 
the right side of the phantom.  Each slice contained a unique numbering system with holes 
created specifically for TLD placement; where the size of each hole was 0.8 cm x 0.8 cm 
diameter and the distance between holes was on a 3.0 cm x 3.0 cm grid.  Where TLDs 
were not used, bone equivalent, tissue equivalent, or lung equivalent plugs, as appropriate, 
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were used to fill in unused holes.  Table 1 provides an example of the numbering 
convention imprinted on each slice of the phantom.  In this Table grid A1 represents the 
right posterior portion of the phantom (e.g., an area where a kidney might be located). 
 
 
 
 
Table 1: Phantom numbering convention for TLD placement per slice. 
A1 A2 A3 A4 A5 A6 A7 
B1 B2 B3 B4 B5 B6 B7 
C1 C2 C3 C4 C5 C6 C7 
D1 D2 D3 D4 D5 D6 D7 
E1 E2 E3 E4 E5 E6 E7 
F1 F2 F3 F4 F5 F6 F7 
 
 
 
 
Appendix A contains thirty-two tables indicative of the placement of each TLD in its 
spective location.  TLDs used inside the phantom throughout this investigation were 
XT-RAD dosimeters (TLD-100) manufactured and distributed by Thermo Electron 
orporation††**.  Each TLD contained a permanent, identification barcode to allow tracking 
                                                
re
D
C
 
††**Thermo Electron Corp. contact Mike Shepherd in Duluth, GA Tel: 770-335-7699  
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in addition to the matrix type of number convention provided with the phantom.  The 
• Kidney 
 Pancreas 
TLD 
pac g erior of the phantom.  A TLD was placed on the center 
torso of the phantom in the anterior (AP), posterior (PA), left lateral (LLAT), and right lateral 
(RLAT) positions.  Table 2 provides a description of the Panasonic UD-802A TLD package. 
 
 
 
absorbed doses were measured in the following organs: 
• Small Intestine 
• Liver 
• Ascending Colon 
• Transverse Colon 
• Gall Bladder 
•
• Right Lung 
After placement of all DXT-RAD dosimeters, four Panasonic model UD-802A 
ka es were placed on the ext
Table 2: Panasonic UD-802 TLD package description. 
 
 Element 1 Element 2 Element 3 Element 4 
Phosphor Li2B4O7  Li2B4O7 CaSO4 CaSO4
Front 
Filtration 
Plastic 
14 mg cm-2
Plastic 
160 mg cm-2
Plastic 
160 mg cm-2
Lead 
0.7 mm UD-802A 
Rear 
Filtration 
Plastic 
14 mg cm-2
Plastic 
160 mg cm-2
Plastic 
160 mg cm-2
Lead 
0.7 mm 
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III.3 Basis for the Selection of Sodium Pertechnetate 
a suitable geometry for exposing the Rando® 
phantom, concern for uniformly distributing a radionuclide over the surface of a suitable 
substrate led to the conclusion that an aqueous solution would likely provide the best 
result.  The selection of Na TcO  provided a solution for meeting this research criterion.  
The criteria for selection of a particular radionuclide are listed below. 
• Easy to manufacture in moderate to large quantities 
te to low cost 
dioactive half-life 
• 
• Common radionuclide 
 This inhibition would have eventually led to large errors in the uniform distribution of the 
radionuclide over the surface of the substrate and, thus, present a non-uniform exposure 
geometry.  Moreover, the use of these common materials made radioactive waste 
generation a major concern, which would subsequently lead to larger waste volumes and 
become cost-prohibitive because of the additional effort required to purchase waste 
containers needed to store the waste. 
 Since Na TcO4 is water soluble, the question of uniform distribution of the 
radionuclide changed to one of whether a non-water soluble substance could be used to 
help distribute the water soluble Na TcO4.  Research efforts revealed that oleic acid 
 During the initial planning to establish 
99m
4
• Ease of transportation and dispersion 
• Modera
• Short ra
Ease of measurement 
• Made in liquid form (to enhance dispersion) 
Early during the design of the exposure geometry, the use of concrete, wood, steel, or 
plastic substrates on which to disperse the Na99mTcO4, presented some minor challenges.  
Overcoming non-uniform distribution of the Na99mTcO4 due to surface tension difficulties of 
the liquid presented the largest of the hurdles.  Surface tension of liquids on the substrate 
impeded the ability of the liquid to smoothly move from one location to another uninhibited. 
99m
99m
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provided such a solution. 
III.4 Basis for the Selection of Oleic Acid 
Like many fatty acids, oleic acid has both a hydrophilic (water attractive) head and a 
molecule that possesses only one double bond in its hydrocarbon sequence and thus is 
also known as a monounsaturated fatty acid.  Ol
and is most abundant in olive oil.  Olive oil contains approximately 55% to 80% oleic acid 
(Brown 1995). 
99m
sense that the hydrophobic tail of the oleic acid will serve to repel the Na99mTcO  while the 
hydrophilic head will be attracted to the 2.5 cm-thick layer of water.  In this manner, if the 
olive oil is resting on top of a thin layer of water due to the hydrophilic head being oriented 
towards the water, then the hydrophobic tail will be oriented upwards and away from the 
99m
hydrophobic tail and the material will be spread uniformly across the surface of the olive oil. 
hydrophobic (water repulsive) tail.  More precisely, oleic acid is an eighteen carbon 
eic acid is a naturally occurring fatty acid 
Given that the Na TcO4 is an aqueous, isotonic saline solution, it makes intuitive 
4
water.  Subsequent application of the Na TcO4 solution will be repelled by the 
III.5 Delivery of the Na99mTcO4
 The addition of the Na99mTcO4 to the semi-circular geometry occurred in two phases 
of each monitoring period.  There were initially three monitoring periods for this 
investigation, but the data from the first monitoring period was disregarded since the 
phantom assembly inexplicably fell over during the evening portion of the exposure causing 
three of the DXT-RAD dosimeters to become damaged and the remaining dosimeters 
found lying in the water, olive oil, and Na99mTcO4.  A monitoring period was defined as one 
in which the total exposure of the TLDs to the penetrating radiation from the Na99mTcO4 
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solution lasted for twenty-four hours.  There were two subsequent monitoring periods and 
during each of these monitoring periods, there were two additions of a 10 mL Na99mTcO4 
solution; where each solution contained 7.4 GBq of 99mTc.  
 Each addition of Na99mTcO  was accomplished by extracting the 10 mL volume from 
a glass vial and injecting the volume onto the surface of the oleic acid.  As an added 
precaution, anti-contamination clothing was worn.  Mechanical agitation of the water and 
oleic acid ensured uniform distribution of the Na TcO4.  The Na TcO4 additions during 
the monitoring period were administered at 0800 Central Standard Time (CST) and at 1400 
CST. 
 Personnel conducting the experiments periodically entered and exited the exposure 
area to document exposure parameters.  From 0800 CST to 2000 CST, radiation 
measurements with the Victoreen Model 450P ionization chamber were conducted every 
four hours.  In addition to collecting dose rate information using the Victoreen 450P, 
integrated dose information was also obtained since this instrument could provide dose 
rate and integrated dose during the entire monitoring period.  The results of the radiation 
measurements are contained in Appendix B.  The integrated dose measurements from the 
Victoreen 450P were used for comparison to dosimeter results as would normally be 
conducted in a practical field exercise.  At the end of each monitoring period, the DXT-RAD 
dosimeters and the TLD packages were removed from the phantom and shipped to the US 
Air Force Radiation Dosimetry Branch at Brooks City-Base, Texas where the TLDs were 
evaluated and results recorded.   
At the conclusion of the final monitoring period, approximately 115 kg of vermiculite 
was needed to absorb the entire volume of water, olive oil, and residual Na99mTcO4.  The 
waste was packaged in strong, tight containers, labeled as radioactive material and allowed 
4
99m 99m
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to decay.  Once the appropriate decay time had passed, the Texas A&M University 
Environmental, Health, and Safety Department was contacted so their radiological 
technicians could transport the waste to a storage area to await final disposition. 
III.6 Full Circle MCNP Simulation 
 After completing model validation, a full three-meter radius circle simulation was 
conducted.  This simulation should provide more useful results applicable to a scenario 
involving gamma-emitting radionuclides.  In general, the estimation methods can be scaled 
according to the amount of radioactivity present.  That is, if the amount of radioactivity 
present in a second event is twice that of the hypothetical event described here, then one 
may expect a two-fold increase in effective dose and organ absorbed dose.  Using MCNP, 
a full circle model simulation was conducted assuming a source of 29.6 GBq.  
 
36 
IV. RESULTS 
IV.1 D  DosimeXT-RAD ter Results
 Exac y 128 DX simete used the s.  The 
measured values and the MCNP-calculated results are presented 4.  
Calculated results in Tables 3 and 4 are from a single MCNP calculation.  Specific DXT-
RAD dosimeter results can be found in Appendix C for for 
period. re -RA s a ac  their 
position inside the organ attempted to take in
dose across the whole organ.  Non-uniformity of the absorbed dose is present since the 
organ t tten be en a depth 
increas nu ns nte as lly.  All 
ind
were not corrected for energy and angular dependent 
ose to the follo rs and modeled 
using MCNP: 
• Small Intestine 
• Kidney 
• 
• 
• Gall Bladder 
 
tl T-RAD do rs were  in each of exposure
in Tables 3 and 
each organ each monitoring 
  There we several DXT D dosimeter ssigned to e h organ and
to account the non-uniformity of the absorbed 
issue will a uate the num r of photons tering the org n.  As tissue 
es, then the mber of photo available for i raction decre e exponentia
ividual DXT-RAD dosimeter results assigned to each organ were averaged.  The results 
responses.  The average absorbed 
wing organs was measured with the DXT-RAD dosimeted
Liver 
Ascending Colon 
• Transverse Colon 
• Pancreas 
• Right Lung 
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Table 3: Organ absorbed dose for monitoring periods 1 and 2, uncorrected for energy 
Organ Monitoring Period 1 Monitoring Period 2 
and angular dependence. 
 
 
Measured 
Results1,2 
(mGy) 
Calculated 
Results3 
(mGy) 
Measured 
Results1,2 
(mGy) 
Calculated 
Results3 
(mGy) 
Small 
Intestine 1.02 ± 0.24 0.85 ± 0.06 1.03 ± 0.12 0.85 ± 0.06 
Kidney 0.79 ± 0.10 0.67 ± 0.05 0.82 ± 0.11 0.67 ± 0.05 
Liver 0.97 ± 0.24 01 ± 0.26 0.82 ± 0.06  0.82 ± 0.06 1.
Ascending 1.04 ± 0.18 0.86 1.13 ± 0.22 0.86 ± 0.07 ± 0.07 Colon 
Transverse 
Colon 0.83 ± 0.13 0.68 ± 0.04 0.87 ± 0.18 0.68 ± 0.04 
Gall Bladder 0 1 0  1 0 0  .90 ± 0.1 .73 ± 0.03 .01 ± 0.1 .73 ± 0.03
Pancreas 0.75 ± 0.11 0.62 ± 0.06 0.76 ± 0.12 0.62 ± 0.06 
Right Lung 0.85 ± 0.17 0.70 ± 0.04 0.88 ± 0.18 0.70 ± 0.04 
1) R round res . 
2) Th express asu ve r a  as the 
sq t of the res  res vi rement 
ance in NCRP Report 58. 
3)  ca  is rela P  error, 
esults are ed up to the nea t one-hundredth
e error 
uare roo
ed in these me
 sum of the squa
rements is the o
of the individual
rall system erro
ults’ standard de
nd is calculated
ation and measu
error, per guid
Error in these lculated results expressed as tive error; MCN  defines relative
xxR σ= , where σ is the standard deviation of the mean and  is the mean. 
 
 
 
t the DXT-RAD dosimeters respond 
diff
respond by a factor of 1.08 when exposed to 140.5 keV photons.  Similarly, in section 
II.3.b (6), LiF TLD material will over-respond by a factor of 1.03 when exposed to 140 
keV photons at an angle of zero to sixty degrees.  Considering both sources of over-
Recall from section II.3.b (5) and II.3.b (6) tha
erently depending upon the photon energy and the angle of incidence between the 
photon and dosimeter.  Data in section II.4.a (5) indicate LiF TLD material will over-
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response, the DXT-RAD dosimeters will over respond by about 11%.  Hence, all 
measured values were divided by a factor of 1.11 to account for this over-response.  
Table 4 shows the results of correcting for the over-response. 
Table 4: Organ absorbed dose for monitoring periods 1 and 2, corrected for energy and 
angular dependence. 
 
Organ Monitoring Period 1 Monitoring Period 2 
 
 
 
 
Measured 
Results1,2 
(mGy) 
Calculated 
Results3 
(mGy) 
Measured 
Results1,2 
(mGy) 
Calculated 
Results3 
(mGy) 
Small 
Intestine 0.92 ± 0.24 0.85 ± 0.06 0.93 ± 0.19 0.85 ± 0.06 
Kidney 0.72 ± 0.10 0.67 ± 0.05 0.74 ± 0.11 0.67 ± 0.05 
Liver 0.87 ± 0.24 0.82 ± 0.06 0.91 ± 0.26 0.82 ± 0.06 
Ascending 
Colon 0.93 ± 0.18 0.86 ± 0.07 1.02 ± 0.22 0.86 ± 0.07 
Transverse 
Colon 0.75 ± 0.13 0.68 ± 0.04 0.78 ± 0.18 0.68 ± 0.04 
Gall Bladder 0.81 ± 0.11 0.73 ± 0.03 0.91 ± 0.10 0.73 ± 0.03 
Pancreas 0.68 ± 0.11 0.62 ± 0.06 0.69 ± 0.12 0.62 ± 0.06 
Right Lung 0.76 ± 0.17 0.70 ± 0.04 0.79 ± 0.18 0.70 ± 0.04 
1) Results are rounded up to the nearest one-hundredth. 
2) The error expressed in these measurements is the overall system error and is calculated as the 
square root of the sum of the squares of the individual results’ standard deviation and measurement 
error, per guidance in NCRP Report 58. 
3) Error in these calculated results is expressed as relative error; MCNP defines relative error, 
xR σ= , where σ is the standard deviation of the mean and x  is the mean. 
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Since tabular data do not provide adequate scaling for comparison purposes, a 
res 
14 and 15. 
 
graphical representation of the data for both monitoring periods is provided in Figu
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Figure 14: Monitoring period number one, organ-specific absorbed dose results. 
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Figure 15: Monitoring period number two, organ-specific absorbed dose results. 
 
 
 
 
IV.2 Panasonic UD-802A TLD Results
 Four Panasonic UD-802A TLDs were used for each of the monitoring periods.  
Measured results for both monitoring periods are presented in Table 5.  In this study, only 
the “deep” values were used.  The results are expressed in units of mSv and are 
automatically corrected for energy and angular dependent responses at the time the 
dosimeters are processed.  This automatic correction is accomplished at the US Air Force 
Radiation Dosimetry Branch by simulating the angular distribution observed in this 
investigation at the Air Force dosimetry laboratory.  The simulated angles are provided as 
input to the algorithm that reports absorbed dose.  In addition, the US Air Force reports a 
uniform ± 10% error for all TLD results‡‡η. 
                                                 
‡‡.Personal communications with Mike Klueber at the US Air Force Radiation Dosimetry Branch. 
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Table 5: Panasonic UD-802 TLD results. 
 
ter Results (mSv) Whole Body Dosime
Badge 
ID Shallow Eye Deep Position 
Monitoring 
Period 
301977 0.62 ± 0.06 0.65 ± 0.07 0.65 ± 0.07 AP 1 
301972 0.54 ± 0.05 0.57 ± 0.06 0.57 ± 0.06 PA 1 
301971 1.08 ± 0.11 1.12 ± 0.11 1.12 ± 0.11 RLAT 1 
301978 0.23 ± 0.02 0.24 ± 0.02 0.24 ± 0.02 LLAT 1 
      
301970 0.72 ± 0.07 0.73 ± 0.07 0.73 ± 0.07 AP 2 
301973 0.56 ± 0.06 0.58 ± 0.06 0.58 ± 0.06 PA 2 
301968 1.17 ± 0.12 1.23 ± 0.12 1.23 ± 0.12 RLAT 2 
301976 0.3 ± 0.03 0.31 ± 0.03 0.31 ± 0.03 LLAT 2 
 
 
 
 The organ-absorbed dose results have little meaning when attempting a 
comparison with values for the Panasonic TLD results.  Modifying factors need to be 
applied, so that the results of the DXT-RAD dosimeters can be compared to the results of 
the Panasonic TLDs.  ICRP Report No. 74 (1996) discusses conversion of an operational 
quantity known as the personal dose equivalent, HP a
rsion coefficient is 1.643 (HP(10)/Ka, in 
units of Gy/Gy).  Now that free-in-air kerma is available, one only need interpolate an 
energy-dependent conversion coefficient for a specific organ from ICRP Report No. 74 
(1996) to convert Ka into absorbed dose, DT. 
(10), to free-in-air kerma, K .  Table 
A.24 in ICRP Report No. 74 (1996) provides energy-dependent conversion coefficients for 
this process and for a 140.5 keV photon, the conve
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 The conversion coefficients are organ specific because of different tissue 
compositions, location within th ffects from other organs.  The 
following conversion coefficients were used
• SI – 0.876 
• Kidney – 0.876 
• Liver – 0.901 
• Ascending Colon – 0.855 
• Transverse Colon – 0.855 
• Gall Bl
• Pancreas –
• Right Lung – 0.952 
 
 Potentiall ce of arms tom resul bsorbed doses 
for the in
however. vided an 
adequate method to determine the factor by which all measured organ absorbed dose 
results should be adjusted.  Taking this ratio shows that the RLAT TLD is approximately a 
factor of 1.72 higher than the AP TLD.  Consequently, all energy and angular-corrected 
organ absorbed doses need to be divided by a factor of 1.72 before comparing their values 
to those derived from the use of organ-specific conversion coefficients. 
Tables 6 and 7 provide the results obtained after applying the conversion 
coefficients to the AP Panasonic TLD and dividing all energy and angular-dependent  
organ absorbed dose results by a factor of 1.72.   
e body, and shielding e
: 
adder – 0.876 
 0.876 
y, the absen  on the phan ted in higher a
dividual organs.  The absence of arms did not significantly affect the AP TLD, 
erefore, taking a ratio of the RLAT TLD compared to the AP TLD pro Th
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Table 6: Organ absorbed doses derived from Panasonic UD-802 TLDs compared to 
DXT-RAD dosimeters. 
 
Organ Monitoring Period 1 
 
DXT 
Absorbed Dose 
after a 1.72 
reduction factor1
(mGy) 
Panasonic Results 
after using 
Conversion 
Coefficients (mGy) 
Small Intestine 0.53 ± 0.14 0.35 ± 0.04 
Kidney 0.41 ± 0.06 0.35 ± 0.04 
Liver 0.50 ± 0.14 0.36 ± 0.04 
Colon (averaged) 0.48 ± 0.09 0.34 ± 0.03 
Gall Bladder 0.47 ± 0.06 0.35 ± 0.04 
Pancreas 0.39 ± 0.06 0.35 ± 0.04 
Right Lung 0.44 ± 0.10 0.38 ± 0.04 
1) Overall system error is calculated as the square root of the sum of the squares of the standard 
deviation and measurement error, per guidance in NCRP Report 58.  Effective doses 
calculated from radiation and tissue weighting factors provided by ICRP (1991). 
2) Note that ICRP (1996) conversion coefficients have been applied. 
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Table 7: Organ absorbed doses derived from Panasonic UD-802 TLDs compared to 
DXT-RAD dosimeters. 
 
Organ Monitoring Period 2 
 
DXT 
Absorbed Dose 
after a 1.72 
reduction factor1
(mGy) 
Panasonic Results 
after using 
Conversion 
Coefficients (mGy) 
Small Intestine 0.53 ± 0.11 0.35 ± 0.04 
Kidney 0.42 ± 0.06 0.35 ± 0.04 
Liver 0.52 ± 0.15 0.36 ± 0.04 
Colon (averaged) 0.52 ± 0.34 ± 0.03  0.12 
Gall Bladder 0.52 ± 0.06 0.35 ± 0.04 
Pancreas 0.40 ± 0.35 ± 0.04  0.07 
Right Lung 0.45 ± 0.10 0.38 ± 0.04 
1) Overall system error is calculated as the square root of the sum of the squares of the standard 
deviation and measurement error, per guidance in NCRP Report 58.  Effective doses 
calculated from radiation and tissue w ghting factors provided by ICRP (1991). 
2) Note that ICRP (1996) conversion coefficients have been applied. 
 
 
Again, since tabular data do not provide adequate scaling for comparison purposes, 
graphical representations of the data for both monitoring periods are provided in Figures 16 
and 17. 
ei
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Figure 16: Graphical representation of the data from Table 7. 
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Figure 17: Graphical representation of the data from Table 8. 
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IV.3 Full Circle Modeling Results
 Since the half-circle model produced acceptable, reproducible agreement between 
measured and calculated results, the MCNP model was considered to be validated.  
Ext dicates that an MCNP simulation of a full-circle source provides more 
useful en applied to a field condition such as an actual radiological 
emergency response.  In this instance, the full circle source was assumed to represent an 
ana eometry that is very likely to occur in an actual RDD 
sce r  MCNP simulation are presented in Table 8 along with derived 
organ-absorbed dose results converted from personal dose equivalent values from a 
sim t scribed in section IV.2, conversion coefficients are required to 
con r  absorbed dose.  So that the results of the absorbed dose can be 
compared to the results of the effective dose, modifying factors need to be applied.  As 
previously discussed, Table A.24 in ICRP Report No. 74 (1996) provides energy-
dependent conversion coefficients for converting effective dose into free-in-air kerma for a 
140.5 keV photon and its value is 1.643 (HP(10)/Ka, units of Gy/Gy).  Now that free-in-air 
kerma is available, one only need interpolate an energy-dependent conversion coefficient 
for a specific organ from ICRP Report No. 74 (1996) to convert Ka into absorbed dose, DT.
ension of logic in
information wh
logue to the ROT geometry; a g
na io.  The results of the
ula ed AP TLD.  As de
ve t effective dose to
47 
 The conversion coefficients are organ specific because of different tissue 
compositions, location within the body, and shielding effects from other organs and the 
following coefficients apply: 
• SI – 0.876 
• Kidney – 0.876
• Liver – 0.901 
• A g Col
• Transverse Co
• D ing Co – 
•  – 0.8
.876
• – 0.95
•  0.952
• Stomach – 0.891 
• .856 
• 876 
• 876 
• Thyroid – 1.174 
 
The conversion coefficients for the SI, kidney, gall bladder, pancreas, spleen, and heart are 
all the same because they are considered to be remainder organs by ICRP (1996).   
 
on – 0.855 
lon – 0.855 
lon 0.855 
scendin
escend
Gall Blad der
• Pancreas – 0
76 
 
 Right Lung 2 
Le g –ft Lun  
Bladder – 0
 Spleen – 0.
Heart – 0.
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Table 8: MCNP results for the full disk simulation. 
 
MCNP Full Circle Simulation Results 
Organ 
Organ Absorbed 
Dose after a 24-
hour exposure to 
29.6 GBq (0.8 Ci) 
of 99mTc1 (mGy) 
Derived Organ 
Absorbed Dose 
from the AP TLD 
Effective Dose3 
(mGy) 
Simulated AP TLD 
Effective Dose 
Results (mSv)2
Bladder 0.86 ± 0.09 0.70 ± 0.12 
Small Intestine 0.99 ± 0.15 0.72 ± 0.12 
Right Kidney 0.76 ± 0.09 0.72 ± 0.12 
Left Kidney 0.76 ± 0.09 0.72 ± 0.12 
Liver 0.87 ± 0.08 0.74 ± 0.12 
Colon 
(averaged) 0.97 ± 0.11 
0.70 ± 0.12 
Gall Bladder 0.92 ± 0.12 0.72 ± 0.12 
Pancreas 0.72 ± 0.08 0.72 ± 0.12 
Spleen 0.94 ± 0.13 0.72 ± 0.12 
Stomach 0.90 ± 0.09 0.73 ± 0.12 
Heart 0.85 ± 0.10 0.72 ± 0.12 
Right Lung 0.82 ± 0.08 0.78 ± 0.12 
Left Lung 0.82 ± 0.08 0.78 ± 0.12 
Thyroid 1.14 ± 0.11 0.96 ± 0.12 
1.35 ± 0.12 
1) GBq is gigabequerels, where 37 gigabequerels is equal to one curie.  Overall system error is calculated 
as the square root of the sum of the squares of the standard deviation and measurement error, per 
guidance in NCRP Report 58.  Effective doses calculated from radiation and tissue weighting factors 
provided by ICRP (1991). 
2) Error in these calculated results are expressed as relative error; MCNP defines relative error, 
xxR σ= , where  is the standard deviation of the mean and σ  is the mean.
considered to be “constants” and thus carry no associated error.  Therefore, total error is equal to the 
in columnar format with error bars for all data sets. 
 
 
3) Since error is not reported with conversion coefficients in ICRP (1996), conversion coefficients are 
error to the results calculated by MCNP in note 2 above. 
 
 
 
A graphical representation of the data for both monitoring periods is provided in Figure 18.  
Note that the data are provided 
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MCNP Calculated Organ Absorbed Dose versus 
Organ Absorbed Dose Derived from Effective Dose
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Figure 18: Graphical representation of the data fromTable 9. 
 
 
 
An estimator that can be inferred from the data above is that in a 24-hour exposure period, 
there are 4.86 x 10-11 m v  3-meter radius circle 
geometry.  This is calculated by dividing the simulated AP TLD value (1.35 mSv) by the 
total amount of radioactivity (29.6 GBq) used in the investigation.  The estimator derived 
here is intended to provide estimated dose based upon the amount of radioactivity present, 
or conversely provide an estimate of the amount of radioactivity present based upon the 
dose received by the recipient. 
S  Bq  (0.18 mrem mCi-1 -1) of Na99mTcO4 in a
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IV.4 Radiological Monitoring Results
The instrumentation used to conduct radiation area monitoring was the Victoreen 
Model 450P (dose and dose rate).  The results of the dose and dose rate information for 
both monitoring periods are provided  an
 
 
 
Table 9: Victoreen 4
 
Radiological Monitoring Parameters1
 in Tables 9 d 10. 
50P dose rate and integrated dose measurements for monitoring 
period number one. 
Time 
(hours) 
Dose Rate 
(mSv h-1) 
Integrated 
Dose (mSv) 
0 0.073 ± 0.015 0 
4 0.05 ± 0.01 0.28 ± 0.06 
82 0.085 ± 0.017 0.6 ± 0.12 
12 0.055 ± 0.01 0.85 ± 0.17 
24 0.015 ± 0.003 1.17 ± 0.23 
1) Results are provided with a uniform error of ± 20% as per the manufacturer’s 
calibration procedures. 
2) Another 7.4 GBq (200 mCi) of Na99mTcO4 added. 
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Table 10: Victoreen 450P dose rate and integrated dose measurements for monitoring 
period number two. 
 
Radiological Monitoring Parameters1
Time (mSv h
Dose Rate Integrated 
-1) Dose (mSv) 
0 0.08 ± 0.016 0 
4 0.052 ± 0.010 0.32 ± 0.06 
82 0.095 ± 0.019 0.68 ± 0.14 
12 0.062 ± 0.012 0.95 ± 0.19 
24 0.017 ± 0.003 1.3 ± 0.26 
1) Results are provided with a uniform error of ± 20% as per the manufacturer’s 
calibration procedures. 
99m
 
2) Another 7.4 GBq (200 mCi) of Na TcO4 added. 
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V. DISCUSSION 
V.1 Comparison of Energy and Angular Corrected Values Versus Non-Corrected Values 
 An inspection of Figures 14 and 15 from section IV.1 reveals that energy and 
angular corrected measured values compare favorably with the calculated results from the 
MCNP modeling.  One will want to note the significance of, or rather consequences of, not 
correcting for energy and angular dependence, however.  A detailed review of the 
lat l review of the graphs in Figures 14 
 geometry of the source term to make appropriate corrections for 
ent of an 
RDD/IND, the range of corrections values for energy and angular dependence needs to be 
known so that an order of magnitude assumption can be made by the IC. 
tabu ed results in Table 3 of section IV.1 and a visua
and 15 indicate that several values,  not corrected for energy and angular dependence, do 
not track well with the calculated values.  Specifically, the lower end of the margins of error 
for the kidney, transverse colon, gall bladder, and pancreas uncorrected for energy and 
angular dependence do not compare favorably with the higher end margins of error for the 
calculated results.  This observation indicates error is introduced when corrections for 
energy and angular dependence are not taken into account.  In this instance, the 
consequence of not correcting for energy and angular dependent responses is that the 
observed values are over-estimated by a factor of 1.11.  The MCNP model, however, does 
make this adjustment and the result is that lower-than-measured values are predicted.  
Moreover, an experimenter will most certainly need to know the energy of the incident 
photons, as well as the
energy and angular dependence.  In a practical field exercise or actual deploym
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V.2 Model Validation
 The results presented in Table 5 of section IV.1 provide DXT-RAD measured organ-
absorbed dose results that are corrected for energy and angular dependence.  Table 4 also 
presents MCNP-calculated organ-absorbed dose results.  Using Figures 14 and 15 to 
visually compare these results confirms that DXT-RAD measured results compare 
favorably to MCNP calculated results.  Therefore, the MCNP model is assumed to be 
validated. 
V.3 Verification of ICRP Conversion Coefficients 
nd organ-absorbed dose are not the same dosimetry concepts, 
 Since DXT-RAD measured organ-absorbed dose results were compared to MCNP 
calculated organ-absorbed dose to validate the MCNP model, verification of ICRP 
conversion coefficients is accomplished by comparing the results of DXT-RAD measured 
organ-absorbed dose to Panasonic TLD-derived organ-absorbed dose.  Tables 6 and 7 in 
section IV.2 provide the results of comparing the DXT-RAD measured organ-absorbed 
doses with the Panasonic TLD-derived organ-absorbed doses.  The Panasonic TLDs 
provide results in terms of effective dose for the whole body (called the Hp(10) by ICRP) 
and, since effective dose a
one must link the two quantities together to demonstrate a relationship.  The quantities are 
linked by converting effective dose into absorbed dose and comparing those derived values 
to measured results.   
V.3.a Description of Panasonic TLD-Derived Organ-Absorbed Dose Results 
 The Panasonic TLD-derived organ absorbed dose results presented in Tables 6 
and 7 were derived from the conversion coefficients found in Table A.24 of ICRP Report 
No. 74 (1996) and the organ specific tables for geometry corrections found in Appendix A 
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to ICRP Report No. 74 (1996).  It is recognized that Table A.24 of ICRP Report No. 74 
(1996) provides these coefficients based upon an ICRU slab and angular dependence 
ctors
nsform Ka into absorbed dose 
(D ), through the use of organ-specific and geometry-specific tabulated data in ICRP 
(1996) Appendix A.  This final conversion requires knowledge of both the energy of the 
incident photon and the geometry of the source.  In this case, the ROT geometry was used 
as a surrogate for the IS geometry.  While not precisely the same geometry, the ROT is 
assumed to be acceptable for use because it is similar to the IS geometry and no other 
suitable analogue exists. 
 The final conversion was to correct for the absence of the arm on the phantom.  It is 
recognized that the organs would have received a smaller magnitude of absorbed dose if 
the phantom possessed arms, but at present this cannot be quantitatively ascertained 
without additional experiments with a phantom that has arms.  To make this correction, a 
reduction ratio between the RLAT TLD for monitoring period number one and the AP TLD 
for monitoring period number one was developed by dividing the value of the AP TLD by 
the value of the RLAT TLD.  This reduction ratio was 1.72 and, thus, all organ absorbed 
fa , but since the TLDs were calibrated on an ICRU slab, this table serves as a suitable 
surrogate to provide this conversion.  The conversion was based on the AP position TLD 
from monitoring period number one.  One of the reasons for using this TLD is that radiation 
workers are trained to wear TLDs in the AP location unless otherwise instructed and first 
responders are similarly trained.  Another reason for selecting this TLD is that the AP TLD 
from monitoring period number two measured marginally higher values due to the residual 
99mTc from the previous monitoring period. 
 Once the first conversion is completed, effective dose is converted to free-in-air 
kerma, Ka.  An additional conversion must be performed to tra
T
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dose results from Table 5 were divided by this factor and results recorded in Tables 6 and 
7.   
 There are two principle reasons why the TLDs from monitoring period number one 
were used to develop the reduction ratio.  First, as stated previously, the results from 
monitoring period number two were slightly higher due the presence of residual 99mTc from 
the previous day.  The other reason for excluding the RLAT TLD and including the AP TLD 
is based on work discussed in ICRP (1996) where the AP position generally receives the 
highest effective doses.  There is, of course, an exception to this where the PA position can 
receive a higher effective dose.  This is because the equivalent dose to the spine is 
somewhat higher since this organ lies close to the surface of the skin and shielding from 
the body is minimized, but that is of little significance here. 
V.3.b Comparison of DXT-RAD Results to Panasonic TLD Results 
 A review of Figure 16 and Figure 17 indicate relatively good agreement between 
DXT-RAD measured organ-absorbed doses and Panasonic TLD-derived organ-absorbed 
doses.  There is a very small disparity among three of the seven organs examined, 
however.  The three disparate organs are the small intestine (SI), colon (includes 
ascending and transverse), and gall bladder.  Specifically, the lower end of the margins of 
error for the DXT-RAD measured organ-absorbed doses (corrected for the missing arms) 
do not compare favorably with the higher end margins of error for the Panasonic TLD-
derived organ-absorbed doses.  This result is not very surprising considering that the 
phantom used is completely tissue equivalent and has a homogenous density.  As defined 
in the MCNP model, the organs modeled had different densities and thus would estimate 
different energy depositions, so a single conversion from the AP TLD would contain some 
inherent error in estimating the true value of organ-absorbed dose.  Moreover, the precise 
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location of these organs is somewhat difficult to identify since the phantom used did not 
possess specific internal organs.  What is worthy to note is that despite these difficulties, 
use of ICRP (1996) conversion coefficients provided reasonable estimates of organ 
absorbed doses in the IS and ROT geometry as long as energy and angular dependence 
were taken into account.  Therefore, the ICRP Report No. 74 (1996) conversion coefficients 
are verified because relatively good agreement exists between DXT-RAD measured organ-
absorbed doses and Panasonic TLD-derived organ-absorbed doses. 
V.4 Discussion of Full Circle Organ-Absorbed Dose Results
 A review of Figure 18 indicates that most organ-absorbed dose results compare 
favorably with the simulated TLD-derived organ-absorbed doses.  There is a very small 
urprising 
disparity among three of the fourteen organs examined.  The three disparate organs are 
the bladder, small intestine (SI), and colon (includes ascending, descending, and 
transverse).  Specifically, the lower end of the margins of error for the MCNP-calculated 
organ-absorbed doses do not compare favorably with the higher end margins of error for 
the simulated TLD-derived organ-absorbed dose.  This result is not very s
considering that the phantom used is completely tissue equivalent and has a homogenous 
density.  Moreover, the precise location of these organs is somewhat difficult to identify 
since the phantom used did not possess specific internal organs.  Additionally, since the 
AP TLD was simulated in this scenario, errors in modeling the precise TLD crystal will 
generate some expected error.  What is worthy to note is that despite these difficulties, the 
use of ICRP (1996) conversion coefficients provided reasonable estimates of organ-
absorbed doses in the IS and ROT geometry as long as energy and angular dependence 
were taken into account. 
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V.5 Comparison of Panasonic TLD Results to Victoreen 450P Values
 Next in comparison is the relationship of Table 5 Panasonic TLD results to the 
integrated dose recorded by the Victoreen Model 450P in Tables 9 and 10.  The Victoreen 
450P ionization chamber was oriented between the chest and waist level and simulated to 
be held by the right hand.  The placement of the Victoreen 450P in this location ensured 
that representative doses and dose rates were recorded consistently.  As a basis of 
comparison, the RLAT TLD from each monitoring period was examined.  The RLAT TLD 
was very close in proximity to the Victoreen 450P so a comparison to these readings is 
TLD from monitoring period 
one was 1.12 ± 0.11 mSv and the Victoreen 450P was 1.17 ± 0.23 mSv.  The 
RLAT TLD from monitoring period two was 1.23 ± 0.12 mSv and the Victoreen 450P was 
1.30 ± 0.26 mSv) indicate that the Victoreen 450P provides an 
reasonable.  The result of the examination is that the RLAT 
number 
1.30 ± 0.26 mSv.  These results indicate that placement of the Victoreen 450P was 
appropriate and that the instrument values were close in agreement to TLD measured 
values.  In a practical sense, the AP TLD will most likely be the TLD worn by a first 
responder and so one must compare the Victoreen 450P value to the AP TLD. 
 The AP TLD measured 0.65 ± 0.07 mSv in monitoring period number one and 0.73 
± 0.07 mSv in monitoring period number two.  Comparison of the AP TLD results with the 
Victoreen 450P values (
overestimate of effective dose by about a factor of two.  This also indicates that the 
Victoreen 450P might possibly serve as a very good real-time indicator of effective dose 
and organ-absorbed dose if the appropriate corrections for energy and angular 
dependence and use of appropriate conversion coefficients for energy and geometry are 
made.  Additional experimentation is needed before this could be justified, however.  One 
will note that the value of 0.73 + 0.07 mSv is somewhat higher than expected when 
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compared to the AP TLD value from monitoring period number one and the corresponding 
RLAT TLD.  It is believed that the Victoreen 450P may have been inadvertently brushed 
against when exchanging dosimeters between experiments.  Even slight movement of the 
Victoreen instrument can change the solid angle of incidence of the radiation field 
significantly since the AP TLD is a small “target.”  Brushing against the Victoreen 
instrument appears to have either shielded the monitoring period number one AP TLD or 
made more visible the monitoring period number two AP TLD.  Additional experimentation 
is needed to verify this hypothesis. 
V.6 Significance to First Responders
 In general, radiation workers and first responders are trained to wear TLDs on the 
chest o
-estimates the organ-absorbed 
dose b
r waist, which is in the AP position.  Also, it is important to note that first responders 
become de facto radiation workers when responding to an incident involving radioactive 
material.  Consequently, first responders are permitted to receive the same amount of 
annual internal and external radiation exposure as other radiation workers in industry.  This 
is an important consideration when one observes the results of comparing the effective 
dose of the TLD to the measured values of organ-absorbed dose.  Also for radiation 
protection purposes the organ-absorbed dose is assumed to be equal to the effective dose 
measured by the TLD.  
 Realizing that the value of the AP TLD in monitoring period number one from Table 
6 in section IV.2 is 0.65 ± 0.07 mSv, the mean value of organ-absorbed dose in Table 7 is 
0.46 ± 0.09 mSv, and the Victoreen 450P effective dose value is 1.17 ± 0.26 mSv, one can 
reason that the AP TLD and Victoreen 450P could represent an overestimate of organ-
absorbed dose.  For example, the AP TLD, on average, over
y a factor of about 1.4 (range of over-response for all measured organs is 1.2 to 1.7) 
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and the Victoreen 450P over-estimates organ-absorbed dose by about a factor of 2.5 
(range of over-response for all measured organs is 2.2 to 3).  Additionally, the Victoreen 
450P over-estimates effective dose by a factor of 1.8 (approximately 2).  This statement, of 
course, is under the assumption that 99mTc is the radioactive material to which the first 
responder is exposed and is in the ROT geometry.  Nevertheless, if a first responder had a 
Victoreen 450P in hand, was responding to an RDD event, and the suspected radionuclide 
was a gamma emitter, the responder could perform a self-estimate of organ-absorbed dose 
and effective dose in the field by dividing the Victoreen 450P integrated reading by a factor 
of three and two, respectively.  
V.7 Importance to the Incident Commander
This notion is important to the IC because of the decisions needed to determine 
placement of hazard boundaries.  Musolino and Harper (2006) propose that for a very large 
source with sophisticated engineering, one could observe a groundshine dose of about 1 
Gy during a 24-hour exposure period  atabout 300 meters from the epicenter of the event.  
In addition, Musolino and Harper (2006) propose that the level at which emergency 
personnel can work unrestricted for five hours is equal to 50 mSv at a distance of about 
100 meters from an intermediate sized source, and up to about 600 meters from a very 
large source with sophisticated engineering.  In this regard, an IC will decide where to 
place such boundaries based upon hand-held instrument readings such as the Victoreen 
450P ionization chamber.  If the Victoreen 450P was used, then the IC could increase the 
boundary limitations by a factor of two, as read by the Victoreen 450P since this virtual 
increase would only result in a first responder receiving the actual expected effective dose 
and associated risk to the responder would not increase. 
In addition to the proposed placement of hazard boundaries above, Musolino and 
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Harper (2006) propose other boundary conditions for evacuation, sheltering in place, and 
initiating protective actions as described in section I of this investigation.  These 
 responder receiving the actual expected organ dose 
recommendations are based upon a 50-year committed dose, and in the case of external 
exposure, this type of decision would be made by the IC based upon hand-held instrument 
readings such as the Victoreen 450P.  Again, we see the over-estimate by the Victoreen for 
organ dose, where the over-estimate is about a factor of three.  Therefore, the IC could 
increase action levels by a factor of three, as read by the Victoreen 450P since this virtual 
increase would only result in a first
and associated risk to the responder would not increase. 
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VI. CONCLUSIONS 
4
dition, the Rando® phantom, Panasonic TLDs, DXT-RAD 
e
s  a o
 Several conclusions can be drawn from this investigation.  The selection of 
Na99mTcO4 served as a good initial source of radioactive material to conduct this 
investigation.  The material was easy to obtain, measure and dispose.  It also had a short 
half-life so that larger quantities could be used without concern for disposal costs.  
Additionally, the liquid form of the Na99mTcO  facilitated dispersal of the material to ensure 
uniform distribution of the source. 
 Another conclusion is that the semi-circular source used to define the IS geometry 
indicates that the ICRP (1996) ROT geometry is a suitable surrogate for the IS geometry 
and is a suitable approximation to that of a radiological dispersal device.  Therefore, the 
first objective is satisfied.  In ad
dosimeters, and Victoreen 450P instruments are commonly found at many facilities.  These 
devices are used to monitor individuals and provide radiological protection and, thus, 
provide a reasonable means to conduct additional experiments with a high degree of 
repeatability.  Therefore, this provides an inexpensive means to conduct future experim nts 
hould funding nd ther resources become available. 
 The additional modeling conducted with a three meter radius full circle source 
confirms that the investigational IS geometry is a suitable surrogate for the ROT geometry, 
MCNP modeling of the human body is accomplished reasonably well, and photon transport 
in air and tissue using MCNP is effective.  The investigation concludes that MCNP 
modeling for different energies of photons and geometries of exposure will be effective and 
reliable.  For more accurate assessments, however, a phantom that contains specific 
organs with related tissue densities is recommended, or even a more homogenous 
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phantom model. 
 This investigation measured organ absorbed doses inside a tissue equivalent 
phantom, compared these values to the effective doses measured using  Panasonic TLDs 
and MCNP modeled results and found that most measured values compared favorably with 
the organ-absorbed dose-derived values from the Panasonic TLD and the MCNP model.  
Therefore, the MCNP model was assumed to be validated and the second, third, and fifth 
objectives are satisfied.  In addition, the Victoreen 450P values of integrated dose 
ompared well with the Panasonic RLAT TLD and, thus, ensured that placement of the 
Victoreen 450P was justified.  This also demonstrated that the Victoreen 450P could 
potentially serve as an estimator of real-time effective dose and organ absorbed dose 
provided that energy and angular dependence could be taken into account.  Therefore, the 
fourth objective is satisfied.  
 In conclusion, the data presented in this investigation indicate that the MCNP model 
developed provided a reasonable approximation to measured results of the simulated RDD 
in an IS geometry with Na99mTcO4 as the source of radioactive material.  Additional 
investigation is needed, however, with other sources of radioactive material such as 137Cs, 
60Co, 192Ir, and 90Sr/90Y.  Along with other sources of radioactive material is the need to use 
an organ-specific phantom that has articulated joints at the shoulders, elbows, hips, and 
knees because a more realistic first responder geometry is for a person to be in the 
crouched position rather than standing vertically.  Such a phantom exists at the Pacific 
Northwest National Laboratory in Richland, Washington, but availability of funding for its 
use and the demands on its use by the existing facility present procurement difficulties.  
Using this type of phantom provides a means to model and measure many different 
exposure geometries for each radionuclide in the investigation and, thus, provide a more 
c
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comprehensive database of doses received from an RDD.  Additional research needs are 
in the areas of particle tracking to determine dose to a specified target.  Of great value 
f interest.  By knowing the spectrum of energies and angles that impinge on internal 
eposi depth.   
would be to obtain the energy and angle of the incident radiation with the dosimetric region 
o
organs, one may be able to make the appropriate corrections more precisely.  This will 
enable any interested party to better determine the non-uniform distribution of energy 
ted in organs versus d
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APPENDIX A 
A.1 itor eriod e DXT AD  Mon ing P  On -R Results 
Table A1: Monitoring period one DXT-RAD results. 
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A.2 Monitoring Period Two DXT-RAD Results
Table A2: Monitoring period two DX -RAD re lts. 
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Slice 24 
17.5 cm 
         
A1  A2  A3  A4   
B1  B2  B3  B4   
C1/814 129/147 C2/989 103.8/11 C3/8020 80.8/92 C4/8417 65.9/74 6 7 8  
D1/821
8 122.8/140 
D2/804
7 
100.1/11
4  82.9/94 D4/8897 68.7/77  D3/8955
E1 E  E  E   2  3  4   
F1  F2  F3  F4   
         
Slice 23 
20 cm 
         
A1  A2  A3  A4   
B1  B2  B3  B4   
C1/879 125.9/144 C2/871 100.4/11 C3/8788 79.1/90 C4/1004 68.3/77  8 1 4 6 
D1/810
9 126/144 
D2/759
7 
100.9/11
5  82.5/93 D4/8880 72.8/82  D3/8819
E1 E  E  E   2  3  4   
F1  F2  F3  F4   
         
         
Slice 22 
22.5 cm 
         
75 
A1  A2  A3  A4   
B1 B  B  B   2  3  4   
C1/828
9 119.6/137 
C2/786
7 98.1/112 C3/8000 74. 85 C4/8369 67.5/76 8/  
D1/754 114.8/131 D2/744 96.7/110 D3/8726 78.3/89 D4/8916 72.2/82  9 4 
E1   E3  E4   E2 
F1  F2  F3  F4   
         
         
Slice 21 
25 cm 
Slice 
Numbe
Numbe
photon/bet
a 
Slice 
eta 
Slice 
Number 
eta 
Slice 
Number/
DXT 
photon/
beta  
r/ 
DXT 
Serial 
r 
(mrad) 
Numbe
r/ 
DXT 
Serial 
Numbe
r 
photon/b
(mrad) 
Number/ 
DXT 
Serial 
photon/b
(mrad) Serial 
Number 
(mrad) 
A1  A2  A3  A4   
B1  B2  B3  B4   
C1/726 110.1/125 C2/920 95.1/108 C3/8333 75. 85 C4/7216 68/77 2 8 1/  
D1/859
3 109.7/125 
D2/863
7 91.4/104 D3/8754 82.8/94 D4/8891 65/73  
E1 E  E  E   2  3  4   
F1  F2  F3  F4   
         
         
Slice 20 
27.5 cm 
         
A1  A2  A3  A4   
B1  B2  B3  B4   
C1  C2/8256 
100.2/11
4 C3/8671 80.3/91 C4/8723 63.1/71  
D1/912
0 114.6/131 
D2/800
2 92.8/105 D3/8412 80.2/91 D4/8087 66.7/75  
E1  E2  79.9/90 E4  E3/7755   
F  1  F  2  F   F43    
         
Slice 19 
30 cm 
         
A1  A2  A3  A4   
B1  B2  B3  B4   
C1  C2/922 93.2/106 C3/8785 81. 92 C4/8889 69.2/78 5 6/  
D1/878
2 101.5/116 
D2/837
2 96.7/110 D3/7441 75. 86 D4/7611 62.9/71 7/  
E1  E2  E3/8544 71.5/81 E4   
76 
F1  F2  F3  F4   
         
         
Slice 18 
32.5 cm 
Slice Slice 
Numbe
r/ 
DXT
Seria
Numbe
r 
photon/bet
Numbe
r/ 
Numbe
r 
photon/b
Slice 
Number/ 
Number 
photon/b
Slice 
Number/
Number 
photon/
  
l 
a 
(mrad) 
DXT 
Serial 
eta 
(mrad) 
DXT 
Serial 
eta 
(mrad) 
DXT 
Serial 
beta 
(mrad) 
A1  A A4   2  A3  
B1  B2  B3  B4   
C1  C2/8366 94.2/107 C3/8928 8   0.2/91 C4 
D1/939
6 97.8/111 
D2/
0 4.5/10 84.4/96 D4/8015 70.2/79  
707 9 7 D3/10009 
E1  E2/7175 96.9/110 E3/8199 83.9/95 E4   
F1  F2  F4    F3 
         
         
Slice 17 
35 cm 
         
A1  A2 4     A3  A
B1  B2  B3  B4   
C1  C2/8365 98.8/112 C3/8215 84.6/96 C4   
D1/767
0 99.8/114 
D2/752
3 97.5/112 D3/8608 86/98 D4/8099 76.2/86  
E1  E2/8797 97.3/111 E3/7545 85.1/96 E4   
F1  F2  F3  F4   
         
         
Slice 16 
37.5 cm 
         
A1  A2  A3  A4   
B1  B2  B3  B4   
C1  C2/7881 84/95 C3/8233 82.7/94 C4   
D1/980
8 103.7/118 
D2/800
9 90.3/103 D3/8427 86.2/98 D4/8026 78.6/89  
E1  E2/8848 91.4/104 E3/8938 95.8/109 E4   
F1  F2  F3  F4   
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APPENDIX B 
B.1 Monitoring Period One Radiological Survey Parameters 
Table B1: Radiological monitoring parameters for monitoring period one. 
 
ogic g Para  Radiol al Monitorin meters
Time 
Integrated 
Dose Dose Rate (mSv h-1) (mSv) 
0 0.073 ± 0.015 0 
4 0.05  0.01 ± 0.28 ± 0.06
8 0.085 ± 0.017 0.6 ± 0.12 
12 0.055 ± 0.01 0.85 ± 0.17
24 0.015 ± 0.003 1.17 ± 0.23
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B.2 Monitoring Period Two Radiological Survey Parameters
Table B1: Radiological monitoring parameters for monitoring period two. 
 
Radiological Monitoring Parameters 
Time Dose (mSv h
R Integrated 
v) 
ate 
-1) Dose (mS
0 0.08 ± 0.016 0  
4 0.052 ± 0.01 .3 ±0 0 2  0.06
8 0.095 ± 0.01 .6 ±9 0 8  0.14
12 ± 0.01 .9 ±0.062 2 0 5  0.19
24 ± 0.00 .  0.017 3 1 3 ± 0.26 
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APPENDIX C 
C.1 er ifMonitoring P iod One Organ-Spec ic Results.
Table C1: The measured and calculated absorbed dose results for the small intestine 
 
Slice/Position M )
Calculated Results3 
m v
Percentage Error easured Results1 
(mSv  ( S ) (%) 
31/A1 1 ± 0.32 .132 1.15 ± 0.05 14.8 
31/C1 1 ± 0.26 .126 1.08 ± 0.05 16.7 
31/E3 0. ± 077 .077 0.62 ± 0.09 24.2 
31/F3 0.91 ± 0.091 0.74 0.07 23.0 ±
31/F5 0 9 09 .79 ± 0.07 0.59 ± 0. 33.9 
30/A1 1.19 ± 0.119 1.02 ± 0.05 16.7 
30/C1 1.13 ± 0.113 0.98 ± 0.06 15.3 
30/E3 0.8 ± 0.08 0.65 ± 0.05 23.1 
    
Av  20.9 erage 1.02 ± 0.242 0.85 ± 0.062
1) Results are rounded up to the nearest tenth and slice/position error is calculated as ±10% error based 
on phone communications with Michael Klueber at the US Air Force Radiation Dosimetry Branch. 
2) Overall system error is calculated as the square root of the sum of the squares of the standard 
deviation and measurement error, per guidance in NCRP Report 58. 
3) Error in these calculated results are expressed as relative error, where MCNP defines relative error, 
xR σ= , where σ is the standard deviation of the mean and x  is the mean, 
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Table C2: The measured and calculated absorbed dose results for the kidney. 
 
Slice/Position Measured Results
1 
(mSv) 
Calculated Results3 
(mSv) 
Percentage Error 
(%) 
31/A3 0.79 ± 0.079 0.65 ± 0.05 21.5 
31/C3 0.78 ± 0.078 0.65 ± 0.06 20.0 
30/A3 0.78 ± 0.078 0.63 ± 0.06 23.8 
30/C3 0.76 ± 0.076 0.61 ± 0.05 24.6 
29/A3 0.84 ± 0.084 0.72 ± 0.04 16.7 
28/A3 0.79 ± 0.079 0.68 ± 0.05 16.2 
28/B3 0.75 ± 0.075 0.65 ± 0.06 15.4 
27/A3 0.85 ± 0.085 0.73 ± 0.04 16.4 
27/B3 0.8 ± 0.08 0.69 ± 0.07 15.9 
    
Average  .  .00.79 ± 0 102 0.67 ± 0 52 18.9 
1) re rounded lculated a  error based 
i i ebe  U ir adiation D ry Branch. 
2) stem error is calculated as the square root of the sum of the squares of the standard 
and measu t r ance RP ep
3) ese calcul u a sed tiv ro  MCNP de lative error, 
Results a  up to the nearest tenth and slice/position error is ca s ±10%
on phone communications w
Overall sy
th M chael Klu r at the S A  Force R osimet
deviation remen erro , per guid  in NC  R ort 58. 
Error in th ated res lts re expres as rela e er r, where fines re
xR σ= , where σ st a on o ea n is the and rd deviati f the m n a d x  is the mean. 
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Table C3: The measured and calculated absorbed dose results for the liver. 
 
Slice/Position Measured Results
1 
(mSv) 
Calculated Results3 
(mSv) 
Percentage Error 
(%) 
29/A1 1.15 ± 0.115 0.91 ± 0.050 26.4 
29/C1 1.15 ± 0.115 0.91 ± 0.049 26.4 
29/C3 0.74 ± 0.074 0.55 ± 0.051 34.5 
29/E1 1.22  1.08  13.0 ± 0.122 ± 0.050
28/A1 1 26 54 .26 ± 0.1 1.1 ± 0.0 14.5 
28/B1 1.09 ± 0.109 1.02 ± 0.048 6.9 
28/C1 1.16 ± 0.116 0.99 ± 0.054 17.2 
28/C3 0.75 ± 0.075 0.59 ± 0.063 27.1 
27/B1 1.09 ± 0.109 0.87 ± 0.049 25.3 
2 19.1 7/C1 1.06 ± 0.106 0.89 ± 0.049 
27/D4 0.71 ± 0.071 0.53 ± 0.088 34.0 
26/B1 1.21 ± 0.121 1.1 ± 0.051 10.0 
26/C1 1.18 ± 0.118 1.04 ± 0.046 13.5 
26/D4 0.69 ± 0.069 0.58 ± 0.09 19.0 
25/C1 1.31 ± 0.131 1.16 ± 0.05 12.9 
25/C2 0.93 ± 0.093 0.74 ± 0.062 25.7 
25/C3 0.83 ± 0.083 0.68 ± 0.058 22.1 
25/C4 0.65 ± 0.065 0.54 ± 0.08 20.4 
25/D1 1.27 ± 0.127 1.15 ± 0.058 10.4 
25/D2 0.91 ± 0.091 0.75 ± 0.061 21.3 
25/D3 0.77 .077 0.62 0.065  ± 0 ± 24.2 
25/D4 0.7 ± 0.07 0.61 ± 0.089 14.8 
24/C1 1.23 ± 0.123 1.08 ± 0.050 13.9 
24/C2 0  .96 ± 0.096 0.81 ± 0.064 18.5 
24/C3 0.78 ± 0.078 0.61 ± 0.064 27.9 
24/C4 0.67  0.51  31.4 ± 0.067 ± 0.073
24/D1 1 15 47 .15 ± 0.1 1 ± 0.0 15.0 
24/D2 0.97 ± 0.097 0.82 ± 0.051 18.3 
24/D3 0.81 ± 0.081 0.68 ± 0.06 19.1 
24/D4 0.69 ± 0.069 0.54 ± 0.093 27.8 
Av  erage 0.97 ± 0.242 0.82 ± 0.062 20.3 
1) Results are rounded up to t culated as ±10% error based 
on phone communications with Michael Klueber at the US Air Force Radiation Dosimetry Branch. 
2) Overall system error is calculated as the square root of the sum of the squares of the standard 
deviation and measurement error, per guidance in NCRP Report 58. 
3) Error in these calculated results are expressed as relative error, where MCNP defines relative error, 
he nearest tenth and slice/position error is cal
xR σ= , where σ is the standard deviation of the mean and x  is the mean. 
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Table C4: The measured and calculated absorbed dose results for the ascending colon. 
 
Slice/Position Measured Results
1 
(mSv) 
Calculated Results3 
(mSv) 
Percentage Error 
(%) 
31/E1 1.15 ± 0.12 0.97 ± 0.057 18.6 
30/E1 1.14 ± 0.11 0.95 ± 0.050 20.0 
29/E3 0.82 ± 0.08 0.67 ± 0.088 22.4 
    
Average 1.04 ± 0.182 0.86 ± 0.072 20.3 
1) Results are rounded up to the nearest tenth and slice/position error is calculated as ±10% error based 
on phone communications with Michael Klueber at the US Air Force Radiation Dosimetry Branch. 
2) Overall system error is calculated as the square root of the sum of the squares of the standard 
deviation and measurement error, per guidance in NCRP Report 58. 
3) Error in these calculated results are expressed as relative error, where MCNP defines relative error, 
xR σ= , where σ is the standard deviation of the mean and x  is the mean. 
Table C5: The measured and calculated absorbed dose results for the transverse colon. 
 
 
 
 
Slice/Position Measured Results
1 
(mSv) 
Calculated Results3 
(mSv) 
Percentage Error 
(%) 
30/F3 0.92 ± 0.09 0.75 ± 0.048 22.7 
30/F5 0.75 ± 0.08 0.61 ± 0.041 23.0 
29/F3 0.9 ± 0.09 0.74 ± 0.047 21.6 
29/F5 0.76 0.08 0.62 0.042 22.6 ± ± 
    
Average 0.83 ± 0.132 0.68 ± 0.042 22.5 
1) Results are rounded up to the nearest tenth and slice/position error is calculated as ±10% error based 
on phone communications with Michael Klueber at the US Air Force Radiation Dosimetry Branch. 
2) Overall system error is calculated as the square root of the sum of the squares of the standard 
viation and measurement error, per guidance in NCRP Report 58. 
ror in these calculated results are expressed as relative error, where M
de
3) Er CNP defines relative error, 
xR σ= , where σ is the standard deviation of the mean and x  is the mean. 
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Table C6: The measured and calculated absorbed dose results for the gall bladder. 
 
Slice/Position Measured Results
1 
(mSv) 
Calculated Results3 
(mSv) 
Percentage Error 
(%) 
28/D2 0.92 ± 0.09 0.75 ± 0.005 22.7 
27/D2 0.85 ± 0.09 0.68 ± 0.056 25.0 
26/D2 0.92 ± 0.09 0.76 ± 0.005 21.1 
    
Average . .00.90 ± 0 112 0.73 ± 0 32 22.9 
1) re rounded a and o n lculated a  error based 
Mi ebe  U Ai adiation D ry Branch. 
2) stem error is calc ted  squa t of the sum of the squares of the standard 
ance R e
3) a sed tiv rr  MCNP de lative error, 
Results a  up to the ne rest tenth 
lu
slice/p sitio error is ca s ±10%
on phone communications w
Overall sy
ith 
ula
chael K
 as the
r at the
re roo
S r Force R osimet
deviation and measurement error, per guid
s
 in NC P R port 58. 
Error in these calculated results re expre as rela e e or, where fines re
xR σ= , where σ s da on o e an is the tan rd deviati f the m an d x  is the mean. 
 
 
 
Table C7: The measured and calculated absorbed dose results for the pancreas. 
 
Slice/Position M e R C t R Percentage Error easur d esults
1 
(mSv) 
alcula ed esults3 
(mSv) (%) 
28/D4 0.71 ± 0.07 0.58 ± 0.057 22.4 
27/C3 0.74 ± 0.07 0.62 ± 0.061 19.4 
26/C3 0.8 ± 0.08 0.66 ± 0.059 21.2 
    
Average .  ± 0112 0.62  0. .062 21.0 0.75 ± 0
4) re rounded a and o n lculated a  error based 
Mi ebe  U Ai adiation D ry Branch. 
5) stem error is calc ted squa t of the sum of the squares of the standard 
dance R e
6) a sed tiv rr  MCNP de lative error, 
Results a  up to the ne rest tenth slice/p sitio error is ca s ±10%
on phone communications w
Overall sy
ith 
ula
chael Klu
 as the 
r at the
re roo
S r Force R osimet
deviation and measurement error, per gui  in NC P R port 58. 
Error in these calculated results re expres as rela e e or, where fines re
xR σ= , where σ s da on o e an is the tan rd deviati f the m an d x  is the mean. 
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Table C8: The measured and calculated absorbed dose results for the right lung. 
 
Slice/Position M e R C t R Percentage Error easur d esults
1 
(mSv) 
alcula ed esults3 
(mSv) (%) 
23/C1 1.25 ± 0.125 1.05 ± 0.043 19.0 
23/C2 0.92 ± 0.092 0.75 ± 0.040 22.7 
23/C3 0.77 ± 0.077 0.63 ± 0.039 22.2 
23/C4 0.66 ± 0.066 0.51 ± 0.048 29.4 
23/D1 1.18 ± 0.118 0.99 ± 0.041 19.2 
23/D2 0.99 ± 0.099 0.85 ± 0.042 16.5 
23/D3 0.8 ± 0.08 0.65 ± 0.048 23.1 
23/D4 0.68 ± 0.068 0.55 ± 0.043 23.6 
22/C1 1.2 ± 0.12 1.01 ± 0.042 18.8 
22/C2 0.92 ± 0.092 0.74 ± 0.018 24.3 
22/C3 0.76 ± 0.076 0.65 ± 0.042 16.9 
22/C4 0.68 ± 0.068 0.56 ± 0.045 21.4 
22/D1 1.16 ± 0.116 0.95 ± 0.044 22.1 
22/D2 0.91 ± 0.091 0.73 ± 0.046 24.7 
22/D3 0.77 ± 0.077 0.64 ± 0.060 20.3 
22/D4 0.66 ± 0.066 0.51 ± 0.054 29.4 
21/C1 1.06 ± 0.106 0.89 ± 0.042 19.1 
21/C2 0.92 ± 0.092 0.75 ± 0.054 22.7 
21/C3 0.82 ± 0.082 0.67 ± 0.044 22.4 
21/C4 0.64 ± 0.064 0.56 ± 0.021 14.3 
21/D1 1.05 ± 0.105 0.87 ± 0.041 20.7 
21/D2 0.93 ± 0.093 0.77 ± 0.041 20.8 
21/D3 0.78   ± 0.078 0.66 ± 0.041 18.2 
21/D4 0 65 0 44 .65 ± 0.0 .52 ± 0.0 25.0 
20/C2 0.94 ± 0.094 0.79 ± 0.043 19.0 
20/C3 0.75 ± 0.075 0.64 ± 0.058 17.2 
20/C4 0.62 ± 0.062 0.51 ± 0.043 21.6 
20/D1 1.04 ± 0.104 0.86 ± 0.041 20.9 
2 ± 20.0 0/D2 0.9 ± 0.09 0.75  0.042 
20/D3 0.72 ± 0.072 0.59 ± 0.051 22.0 
20/D4 0.62 ± 0.062 0.52 ± 0.044 19.2 
20/E3 0.77 ± 0.077 0.64 ± 0.061 20.3 
19/C2 0.84 ± 0.084 0.71 ± 0.043 18.3 
19/C3 0.77 ± 0.077 0.63 ± 0.044 22.2 
19/C4 0.69 ± 0.069 0.58 ± 0.043 19.0 
19/D1 1 ± 0.1 0.81 ± 0.040 23.5 
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19/D2 0.92 ± 0.092 0.75 ± 0.041 22.7 
19/D3 0.79 ± 0.079 0.68 ± 0.047 16.2 
19/D4 0.67 ± 0.067 0.59 ± 0.038 13.6 
19/E3 0.72 ± 0.072 0.58 ± 0.045 24.1 
18/C2 0.94 ± 0.094 0.77 ± 0.044 22.1 
18/C3 0.77 ± 0.077 0.61 ± 0.043 26.2 
18/D1 0.97 ± 0.097 0.81 ± 0.043 19.8 
18/D2 0.9 ± 0.09 0.77 ± 0.045 16.9 
18/D3 0.79 ± 0.079 0.67 ± 0.050 17.9 
18/D4 0.7 ± 0.07 0.55 ± 0.044 27.3 
18/E2 0.97 ± 0.097 0.85 ± 0.056 14.1 
18/E3 0.85 ± 0.085 0.74 ± 0.018 14.9 
17/C2 0  .86 ± 0.086 0.68 ± 0.022 26.5 
17/C3 0.81 ± 0.081 0.66 ± 0.038 22.7 
17/D1 0.93 ± 0.093 0.79 ± 0.046 17.7 
17/D2 0.88 ± 0.088 0.74 ± 0.044 18.9 
17/D3 0.82 ±  ± 0.082 0.71  0.041 15.5 
17/D4 0 73 0 39 .73 ± 0.0 .61 ± 0.0 19.7 
17/E2 0.88 ± 0.088 0.76 ± 0.043 15.8 
17/E3 0.86 ± 0.086 0.75 ± 0.043 14.7 
16/C2 0.8 ± 0.08 0.65 ± 0.076 23.1 
16/C3 0.73 ± 0.073 0.58 ± 0.071 25.9 
1 ± 17.7 6/D1 0.93 ± 0.093 0.79  0.049 
16/D2 0.83 ± 0.083 0.71 ± 0.047 16.9 
16/D3 0.82 ± 0.082 0.68 ± 0.048 20.6 
16/D4 0.78 ± 0.078 0.65 ± 0.043 20.0 
16/E2 0.83 ± 0.083 0.7 ± 0.046 18.6 
16/E3 0.8 ± 0.08 0.69 ± 0.038 15.9 
    
Average 0.85 ± 0.172 0.70 ± 0.042 20.4 
1) Results are rounded up to the nearest tenth and slice/position error is calculated as ±10% error based 
on phone communications with Michael Klueber at the US Air Force Radiation Dosimetry Branch. 
2) Overall system error is calculated as the square root of the sum of the squares of the standard 
deviation and measurement error, per guidance in NCRP Report 58. 
3) Error in these calculated results are expressed as relative error, where MCNP defines relative error, 
xR σ= , where σ is the standard deviation of the mean and x  is the mean. 
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C.2 Monitoring Period Two Organ Specific Results
Table C9: The measured and calculated absorbed dose results for the small intestine. 
 
Slice/Position M e R C t R
3 Percentage Error easur d esults1 
(mSv) 
alcula ed esults
(mSv) (%) 
31/A1 1.23 ± 0.12 1.15 ± 0.045 7.0 
31/C1 1.11 ± 0.11 1.08 ± 0.045 2.8 
31/E3 0.91 ± 0.09 0  .62 ± 0.085 46.8 
31/F3 0.9 ± 0.09 0.74 ± 0.065 21.6 
31/F5 0.8 ± 0.08 0.59 ± 0.085 35.6 
30/A1 1.28 ± 0.13 1.02 ± 0.049 25.5 
30/C1 1.08 0.11 0.98 0.055 10.2 ± ± 
30/E3 0 9 0.6 50 .92 ± 0.0 5 ± 0.0 41.5 
    
Average 1.03 ± 0.192 0.85 ± 0.062 23.9 
1) Results are rounded up to the nearest tenth and slice/position error is calculated as ±10% error based 
on phone communications with Michael Klueber at the US Air Force Radiation Dosimetry Branch. 
2) Overall system error is calculated as the square root of the sum of the squares of the standard 
viation and measurement error, per guidance in NCRP Report 58. de
3) Error in these calculated results are expressed as relative error, where MCNP defines relative error, 
xR σ= , where σ is the standard deviation of the mean and x  is the mean, 
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Table C10: The measured and calculated absorbed dose results for the kidney. 
 
Slice/Position Measured Results
1 
(mSv) 
Calculated Results3 
(mSv) 
Percentage Error 
(%) 
31/A3 0.9 ± 0.09 0.65 ± 0.05 38.5 
31/C3 0.78 ± 0.078 0.65 ± 0.06 20.0 
30/A3 0.76 ± 0.076 0.63 ± 0.06 20.6 
30/C3 0.77 ± 0.077 0.61 ± 0.049 26.2 
29/A3 0.86 ± 0.086 0.72 ± 0.0365 19.4 
28/A3 0.87 ± 0.087 0.68 ± 0.05 27.9 
28/B3 0.79 ± 0.079 0.65 ± 0.055 21.5 
27/A3 0.83 ± 0.083 0.73 ± 0.0375 13.7 
27/B3 0.79 ± 0.079 0.69 ± 0.065 14.5 
    
Average  . 7 .0.82 ± 0 112 0.6 ± 0 052 22.5 
1) re rounded lculated as ±10% error based 
on phone communications wi i lueber a  Branch. 
2) Overall system error is calculated as the square root of the sum of the squares of the standard 
deviation and measurement error, per guidance in NCRP Report 58. 
3) Error in these calculated results are expressed as relative error, where MCNP defines relative error, 
Results a  up to the nearest tenth and slice/position error is ca
t the US Air Fth M chael K orce Radiation Dosimetry
xR σ= , where σ is the standard deviation of the mean and x  is the mean. 
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Table C11: The measured and calculated absorbed dose results for the liver. 
 
Slice/Position Measured Results
1 
(mSv) 
Calculated Results3 
(mSv) 
Percentage Error 
(%) 
29/A1 1.34 ± 0.13 0.91 ± 0.050 47.3 
29/C1 1.14 ± 0.11 0.91 ± 0.049 25.3 
29/C3 0.83 ± 0.08 0.55 ± 0.051 50.9 
29/E1 1.16 ± 0.12 1.08 ± 0.050 7.4 
28/A1 1.21 ± 0.12 1.1 ± 0.054 10.0 
28/B1 1.27 ± 0.13 1.02 ± 0.048 24.5 
28/C1 1.15 ± 0.12 0.99 ± 0.054 16.2 
28/C3 0.77 ± 0.08 0.59 ± 0.063 30.5 
27/B1 1.24 ± 0.12 0.87 ± 0.049 42.5 
27/C1 1.15 ± 0.12 0.89 ± 0.049 29.2 
27/D4 0.71 ± 0.07 0.53 ± 0.088 34.0 
26/B1 1.36 ± 0.14 1.1 ± 0.051 23.6 
26/C1 1.2 ± 0.12 1.04 ± 0.046 15.4 
26/D4 0.69 ± 0.07 0.58 ± 0.090 19.0 
25/C1 1.32 ± 0.13 1.16 ± 0.050 13.8 
25/C2 0.98 ± 0.10 0.74 ± 0.062 32.4 
25/C3 0.8 ± 0.08 0.68 ± 0.058 17.6 
25/C4 0.68 ± 0.07 0.54 ± 0.080 25.9 
25/D1 1.3 ± 0.13 1.15 ± 0.058 13.0 
25/D2 0.96 ± 0.10 0.75 ± 0.061 28.0 
25/D3 0.85 ± 0.09 0.62 ± 0.065 37.1 
25/D4 0.66 ± 0.07 0.61 ± 0.089 8.2 
24/C1 1.29 ± 0.13 1.08 ± 0.050 19.4 
24/C2 1.04 ± 0.10 0.81 ± 0.064 28.4 
24/C3 0.81 ± 0.08 0.61 ± 0.064 32.8 
24/C4 0.66 ± 0.07 0.51 ± 0.073 29.4 
24/D1 1.23 ± 0.12 1 ± 0.047 23.0 
24/D2 1 ± 0.10 0.82 ± 0.051 22.0 
24/D3 0.83 ± 0.08 0.68 ± 0.060 22.1 
24/D4 0.69 ± 0.07 0.54 ± 0.093 27.8 
Average 1.01 ± 0.262 0.82 ± 0.062 25.2 
1) Results are rounded up to the nearest tenth and slice/position error is calculated as ±10% error based 
on phone communications with Michael Klueber at the US Air Force Radiation Dosimetry Branch. 
2) Overall system error is calculated as the square root of the sum of the squares of the standard 
deviation and measurement error, per guidance in NCRP Report 58. 
3) Error in these calculated results are expressed as relative error, where MCNP defines relative error, 
xR σ= , where σ is the standard deviation of the mean and x  is the mean. 
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Table C12: The measured and calculated absorbed dose results for the ascending 
colon. 
 
Slice/Position Measured Results
1 
(mSv) 
Calculated Results3 
(mSv) 
Percentage Error 
(%) 
31/E1 1.28 ± 0.13 0.97 ± 0.057 32.0 
30/E1 1.26 ± 0.13 0.95 ± 0.050 32.6 
29/E3 0.85 ± 0.09 0.67 ± 0.088 26.9 
    
Average 1.13 ± 0.222 0.86 ± 0.072 30.5 
1)  
on phone communications with Michael Klueber at the US Air Force Radiation Dosimetry Branch. 
Overall system error is calculated as the square root of the sum of 
Results are rounded up to the nearest tenth and slice/position error is calculated as ±10% error based
2) the squares of the standard 
deviation and measurement error, per guidance in NCRP Report 58. 
3) Error in these calculated results are expressed as relative error, where MCNP defines relative error, 
xR σ= , where σ is the standard deviation of the mean and x  is the mean. 
 
 
 
Table C13: The measured and calculated absorbed dose results for the transverse 
colon. 
 
Slice/Position M e  Calculate(mSv)
Percentage Error easur d Results1
(mSv) 
d Results3 
 (%) 
30/F3 1.02 ± 0.10 36.0 0.75 ± 0.048 
30/F5 0.72 ± 0.07 0.61 0.041 18.0 ± 
29/F3 1.01 ± 0.10 0.74 ± 0.047 36.5 
29/F5 0.72 ± 0.07 0.62 ± 0.042 16.1 
    
A 26.7 verage 0.87 ± 0.182 0.68 ± 0.042
1) Results are rounded up to the nearest tenth and slice/position error is calculated as ±10% error based 
on phone communications with Michael Klueber at the US Air Force Radiation Dosimetry Branch. 
2) Overall system error is calculated as the square root of the sum of the squares of the standard 
deviation and measurement error, per guidance in NCRP Report 58. 
3) Error in these calculated results are expressed as relative error, where MCNP defines relative error, 
xR σ= , where σ is the standard deviation of the mean and x  is the mean. 
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Table C14: The measured and calculated absorbed dose results for the gall bladder. 
Slice/Position Measured Results
1 
(mSv) 
Calculated Results3 
(mSv) 
r 
) 
 
Percentage Erro
(%
28/D2 1.03 ±  0.005 27.2 0.102 0.75 ± 
27/D2 1.02 0.072 ± 25.9 ± 0.68 0.056 
26/D2  0.76  0.97 ± 0.101 ± 0.005 26.0
    
Average  . 3  1.01 ± 0 102 0.7  ± 0.032 26.4
1) re rounded e a h and osition lculated as ±10% error based 
i i lueber  Branch. 
2) stem error is calculated as the square root of the sum of the squares of the standard 
 per guidance in NCRP Report 58. 
3) Error in these calculated results are expressed as relative error, where MCNP defines relative error, 
Results a  up to th  ne rest tent slice/p
 at the US Air F
error is ca
orce Radiation Dosimetryon phone communications w
Overall sy
th M chael K
deviation and measurement error,
xxR σ= , where σ standard deviation of the mean and  is the  is the mean. 
 
 
 
Table C15: The measured and calculated absorbed dose results for the pancreas. 
 
Slice/Position M e  C ted R Percentage Error easur d Results
1
(mSv) 
alcula esults3 
(mSv) (%) 
28/D4 0.68 ± 0.07 0.58 ± 0.057 17.2 
27/C3 0.80 ± 0.08 0.62 ± 0.061 29.0 
26/C3 0.81 ± 0.08 0.66 ± 0.059 22.7 
    
Average  .  .0 23.0 0.76 ± 0 122 0.62 ± 0 62
1) re rounded e a h and os  lculated a  error based 
i he US Air Force Radiation Dosimetry Branch. 
2) stem error is calculated as the square root of the sum of the squares of the standard 
deviation and measurement error, per guidance in NCRP Report 58. 
3) Error in these calculated results are expressed as relative error, where MCNP defines relative error, 
Results a  up to th  ne
th Michael Klueber at t
rest tent slice/p ition error is ca s ±10%
on phone communications w
Overall sy
xR σ= , where σ st a tion o ea n is the and rd devia f the m n a d x  is the mean. 
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Table C16: The measured and calculated absorbed dose results for the right lung. 
 
Slice/Position Measured Results
1 Calculated Results3 Percentage Error 
(%) (mSv) (mSv) 
23/C1 1.26 ± 0.13 20.0 1.05 ± 0.043 
23/C2 1.00 ± 0.10 0.75 ± 0.040 33.3 
23/C3 0.79 0.08 ± 0.63 ± 0.039 25.4 
23/C4 0  0.51.68 ± 0.07 ± 0.048 33.3 
23/D1 1.26 ± 0.13 0.99 ± 0.041 27.3 
23/D2 1.01 ± 0.10 0.85 ± 0.042 18.8 
23/D3 0.83 0.08 ± 0.048 27.7 ± 0.65
23/D4 0.73  0.07 0.55 ± 0.043 ± 32.7 
22/C1 1.2 ± 18.8 ± 0.12 1.01 0.042 
22/C2 0.98 ± 0.10 0.74 ± 0.018 32.4 
22/C3 0.75 ± 0.08 0.65 ± 0.042 15.4 
22/C4 0.68 ± 0.07 0.56 ± 0.045 21.4 
22/D1 1.14 ± 0.11 0.95 ± 0.044 20.0 
22/D2 0.97 ± 0.10 0.73 ± 0.046 32.9 
22/D3 0.78 ± 0.08 0.64 ± 0.060 21.9 
22/D4 0.72 0.07 41.2 ± 0.51 ± 0.054 
21/C1 1.1 ± 0.11 0.89 ± 0.042 23.6 
21/C2 0.95 ± 0.10 0.75 ± 0.054 26.7 
21/C3 0.75 ± 0.08 0.67 ± 0.044 11.9 
21/C4 0.68 ± 0.07 0.56 ± 0.021 21.4 
21/D1 1.1 ± 0.11 0.87 ± 0.041 26.4 
21/D2 0.91 ± 0.09 0.77 ± 0.041 18.2 
21/D3 0.83 ± 0.08 0.66 ± 0.041 25.8 
21/D4 0.65 ± 0.07 0.52 ± 0.044 25.0 
20/C2 1.0 ± 0.10 0.79 ± 0.043 26.6 
20/C3 0.8 ± 0.08 0.64 ± 0.058 25.0 
20/C4 0.63 ± 0.06 0.51 ± 0.043 23.5 
20/D1 1.15 ± 0.12 0.86 ± 0.041 33.7 
20/D2 0.93 ± 0.09 0.75 ± 0.042 24.0 
20/D3 0.8 ± 0.08 0.59 ± 0.051 35.6 
20/D4 0.67 ± 0.07 0.52 ± 0.044 28.8 
20/E3 0.8 ± 0.08 0.64 ± 0.061 25.0 
19/C2 0.93 ± 0.09 0.71 ± 0.043 31.0 
19/C3 0.82 ± 0.08 0.63 ± 0.044 30.2 
19/C4 0.69 ± 0.07 0.58 ± 0.043 19.0 
19/D1 1.02 ± 0.10 0.81 ± 0.040 25.9 
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19/D2 0.97 ± 0.10 0.75 ± 0.041 29.3 
19/D3 0.76 ± 0.08 68 ± 0.047 11.8 0.
19/D4 0.63 ± 0.06 0.59 ± 0.038 6.8 
19/E3 0.72 ± 0.07 0.58 ± 0.045 24.1 
18/C2 0.94 ± 0.09 0.77 ± 0.044 22.1 
18/C3 0.8 ± 0.08 0.61 ± 0.043 31.1 
18/D1 0.98 ± 0.10 0.81 ± 0.043 21.0 
18/D2 0.95 ± 0.10 0.77 ± 0.045 23.4 
18/D3 0.84 ± 0.08 0.67 ± 0.050 25.4 
18/D4 0.7 ± 0.07 0.55 ± 0.044 27.3 
18/E2 0.97 ± 0.10 0.85 ± 0.056 14.1 
18/E3 0.84 ± 0.08 0.74 ± 0.018 13.5 
17/C2 0.99 ± 0.10 0.68 ± 0.022 45.6 
17/C3 0.85 ± 0.09 0.66 ± 0.038 28.8 
17/D1 1.0 ± 0.10 0.79 ± 0.046 26.6 
17/D2 0.98 ± 0.10 0.74 ± 0.044 32.4 
17/D3 0.86 ± 0.09 0.71 ± 0.041 21.1 
17/D4 0.76 ± 0.08 0.61 ± 0.039 24.6 
17/E2 0.97 ± 0.10 0.76 ± 0.043 27.6 
17/E3 0.85 ± 0.09 0.75 ± 0.043 13.3 
16/C2 0.84 ± 0.08 0.65 ± 0.076 29.2 
16/C3 0.83 ± 0.08 0.58 ± 0.071 43.1 
16/D1 1.04 ± 0.10 0.79 ± 0.049 31.6 
16/D2 0.9 ± 0.09 0.71 ± 0.047 26.8 
16/D3 0.86 ± 0.09 0.68 ± 0.048 26.5 
16/D4 0.79 ± 0.08 0.65 ± 0.043 21.5 
16/E2 0.91 ± 0.09 0.7 ± 0.046 30.0 
16/E3 0.96 ± 0.10 0.69 ± 0.038 39.1 
    
Average 0.88 ± 0.182 0.70 ± 0.092 25.7 
1) Results are rounded up to the nearest tenth and slice/position error is calculated as ±10% error based 
 calculated results are expressed as relative error, where MCNP defines relative error, 
on phone communications with Michael Klueber at the US Air Force Radiation Dosimetry Branch. 
2) Overall system error is calculated as the square root of the sum of the squares of the standard 
deviation and measurement error, per guidance in NCRP Report 58. 
3) Error in these
xR σ= , where σ is the standard deviation of the mean and x  is the mean. 
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